Archive for the ‘Hormone Clinic’ Category

The Mayo Clinic says hormone therapy is only used for breast cancers that are found to have receptors for estrogen or progesterone. Doctors refer to these types of cancers as estrogen receptor positive (ER positive) or progesterone receptor positive (PR positive). Doctors who specialize in analyzing blood and body tissue will study a sample of cancer cells to see if they have receptors for estrogen or progesterone.

It is important not to mistake hormone therapy for breast cancer with menopausal hormone therapy, which is sometimes called hormone replacement therapy, advises the National Cancer Institute. With menopause treatments, progesterone and estrogen may be used to relieve symptoms of menopause. Cancer hormone treatment does the opposite. The therapy blocks the growth of ER or PR positive breast cancer cells. Typically, drugs are used to stop estrogen and progesterone from helping breast cancer cells grow; otherwise, drugs or surgery will be used to keep the ovaries from making these hormones. Radiation therapy aimed at the ovaries also may help stop hormone production.

Continue reading here:
Hormone therapy is an option to treat breast cancer - Dayton Daily News

New results to be presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.

Adjuvant treatments, such as chemotherapy, radiation therapy or targeted therapies, are not usually offered to ILC patients after surgery as the disease is slow growing and often responds well to hormone treatment alone. So far, there has been little evidence that such treatments improve outcomes, but they can affect people's quality of life.

However, the 70-gene signature test (commercially known as MammaPrint) identified some ILC patients whose genetic make-up puts them at high risk of the cancer recurring if they are treated with hormone therapy alone. These patients may benefit from additional adjuvant therapy.

ILC is a type of cancer that begins in the milk glands (lobules) of the breast. It becomes invasive when the cancer cells start spreading beyond the lobules and has the potential to spread to the lymph glands and other parts of the body. It affects about 10% of people with invasive breast cancer. By comparison, invasive ductal carcinoma (IDC) accounts for about 80% of breast cancers in women. It begins in the milk ducts and grows into the surrounding breast tissue, and is often treated with radiation, chemotherapy, hormone therapy or targeted therapies such as trastuzumab and T-DM1, in addition to surgery.

Dr Otto Metzger, a medical oncologist at the Dana-Farber Cancer Institute and assistant professor at Harvard Medical School, Boston, USA, told the conference: "The decision about whether or not to treat patients diagnosed with invasive lobular carcinoma with chemotherapy is difficult. Results from earlier research, which I carried out with Professor Christos Sotiriou while I was at the Institut Jules Bordet in Belgium, indicated that 10 to 15% of ILC cases were classified as high-risk at a genomic level. These had worse survival outcomes when compared to those classified as low-risk."

In a statement before the conference, the principle investigator of the MINDACT trial, Professor Fatima Cardoso, Director of the Breast Unit of the Champalimaud Clinical Centre in Lisbon, Portugal, said: "In this sub-study of the MINDACT trial, we have investigated further the biology of ILC and have identified a subset of ILC patients who could potentially benefit from chemotherapy or other adjuvant treatments. Here we report for the first time the utility of the 70-gene signature test in a large group of patients with ILC in the MINDACT randomised phase III clinical trial. These results are important for clinicians to help them choose a precise treatment approach tailored to the individual patient. This work was possible due to generous support of the Breast Cancer Research Foundation."

A total of 6,693 women with early-stage breast cancer enrolled in the international MINDACT trial. Of these, 5,313 patients were included in the current analysis: 487 women had ILC, including 255 classic cases of the disease and 232 variants, and 4,826 had IDC. The tissue samples were reviewed by a central pathology service to ensure consistency in categorising the different types and variants of cancer. The patients were followed for an average (median) of five years after diagnosis.

The 70-gene signature test classified 16.2% of ILC as high genomic risk and 39.1% of IDC as high genomic risk. By comparing classic ILC to variants of ILC, it classified 10.2% of classic ILC and 22.8% of ILC variants as high genomic risk.

The researchers found that estimates for the proportion of patients surviving without the disease recurring (disease-free survival, DFS) or without the disease spreading to other parts of the body (distant metastases-free survival, DMFS) at five years were similar for both ILCs and IDCs that had been classified as high risk by the 70-gene signature test. DFS was 87.1% for IDC and 84.6% for ILC. DMFS was 92.3% for IDC and 89.4% for ILC.

Estimates for IDCs and ILCs that the 70-gene signature test classified as low risk were also similar. DFS was 92.5% for IDC and 92% for ILC. DMFS was 96.5% for IDC and 96.6% for ILC.

Dr Metzger said: "We found that DMFS and DFS estimates were similar for ILC and IDC classified as either low or high-risk by the 70-gene signature test. This suggests that the test has prognostic value for ILC. The incorporation of biological features defined by the 70-gene signature test in the treatment decisions for patients diagnosed with ILC should facilitate a complex decision-making process, that includes the extent of disease, other health conditions and patients' preferences."

Chair of EBCC12, Professor Nadia Harbeck, of the University of Munich (LMU), Germany, who was not involved with the study, commented: "The results of this study show that the 70-gene signature test may play a useful role in the clinic when doctors are considering whether their patients with invasive lobular carcinoma might benefit from treatments such as chemotherapy in addition to surgery.

"As only about 10% of patients with invasive breast cancer have ILC and, in this study, the 70-gene signature test classified only 16.2% as high-risk ILC, a retrospective series of patients could have failed to identify a potential benefit for adjuvant therapies from such a small sub-group of patients. This analysis of over 5,000 women with early breast cancer in the MINDACT trial is an important contribution to our knowledge of the best way of treating these women."

See original here:
Genetic test identifies invasive lobular carcinomas that are at high risk of recurring - Science Codex

Low glucocorticoid receptor (GR) expression led to excessive inflammation and lung damage by neutrophils through enhancing the expression of CXCL8 and other cytokines. Credit: Professor Heung Kyu Lee, KAIST. Created with Biorender.com

Airway cell analyses showing an activated immune axis could pinpoint the COVID-19 patients who will most benefit from targeted therapies.

KAIST researchers have identified key markers that could help pinpoint patients who are bound to get a severe reaction to COVID-19 infection. This would help doctors provide the right treatments at the right time, potentially saving lives. The findings were published in the journal Frontiers in Immunology.

Peoples immune systems react differently to infection with SARS-CoV-2, the virus that causes COVID-19, ranging from mild to severe, life-threatening responses.

To understand the differences in responses, Professor Heung Kyu Lee and PhD candidate Jang Hyun Park from the Graduate School of Medical Science and Engineering at KAIST analysed ribonucleic acid (RNA) sequencing data extracted from individual airway cells of healthy controls and of mildly and severely ill patients with COVID-19. The data was available in a public database previously published by a group of Chinese researchers.

Our analyses identified an association between immune cells called neutrophils and special cell receptors that bind to the steroid hormone glucocorticoid, Professor Lee explained. This finding could be used as a biomarker for predicting disease severity in patients and thus selecting a targeted therapy that can help treat them at an appropriate time, he added.

Severe illness in COVID-19 is associated with an exaggerated immune response that leads to excessive airway-damaging inflammation. This condition, known as acute respiratory distress syndrome (ARDS), accounts for 70% of deaths in fatal COVID-19 infections.

Scientists already know that this excessive inflammation involves heightened neutrophil recruitment to the airways, but the detailed mechanisms of this reaction are still unclear.

Lee and Parks analyses found that a group of immune cells called myeloid cells produced excess amounts of neutrophil-recruiting chemicals in severely ill patients, including a cytokine called tumour necrosis factor (TNF) and a chemokine called CXCL8.

Further RNA analyses of neutrophils in severely ill patients showed they were less able to recruit very important T cells needed for attacking the virus. At the same time, the neutrophils produced too many extracellular molecules that normally trap pathogens, but damage airway cells when produced in excess.

The researchers additionally found that the airway cells in severely ill patients were not expressing enough glucocorticoid receptors. This was correlated with increased CXCL8 expression and neutrophil recruitment.

Glucocorticoids, like the well-known drug dexamethasone, are anti-inflammatory agents that could play a role in treating COVID-19. However, using them in early or mild forms of the infection could suppress the necessary immune reactions to combat the virus. But if airway damage has already happened in more severe cases, glucocorticoid treatment would be ineffective.

Knowing who to give this treatment to and when is really important. COVID-19 patients showing reduced glucocorticoid receptor expression, increased CXCL8 expression, and excess neutrophil recruitment to the airways could benefit from treatment with glucocorticoids to prevent airway damage. Further research is needed, however, to confirm the relationship between glucocorticoids and neutrophil inflammation at the protein level.

Our study could serve as a springboard towards more accurate and reliable COVID-19 treatments, Professor Lee said.

Reference: Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19 by Jang Hyun Park and Heung Kyu Lee, 28 August 2020, Frontiers in Immunology.DOI: 10.3389/fimmu.2020.02145

This work was supported by the National Research Foundation of Korea, and Mobile Clinic Module Project funded by KAIST.

Follow this link:
Researchers Identify Key Biomarker That Predicts Who Will Have Severe COVID-19 - SciTechDaily

Dr Derek Glidden and the team at Nottinghams transgender clinic have had a tough few months navigating the coronavirus pandemic while managing one of the longest waiting lists in the NHS.

Clinical lead Dr Glidden, who works at the Hockley-based centre, explained how the clinic has managed to keep operating its much-needed service in a world where everything has changed.

The Nottingham Centre for Transgender Health takes referrals from all over the country for people over the age of 17 but a long waiting list means people are currently waiting around three years for an initial appointment.

Keen not to add to the growing list, Dr Glidden and the team were faced with a huge challenge in March to keep the service going without seeing patients in person.

The clinic, which is the second largest in the UK, receives around 1,000 referrals a year from healthcare professionals.

There is a year-on-year increase in referrals and the centres main priority is to improve access.

Dr Glidden said: Weve been one of few services able to continue to start people on gender-affirming treatments.

Our patients can face inequalities when it comes to transgender healthcare and the waiting lists are not echoed in any other place in the NHS.

For the vast majority of our patients, the treatment is not a want, its a need. Its life-changing treatment for the patients we see.

It was an extremely challenging time but we maintained our much-needed service.

Reflecting on the past few months he said: It was a challenging time but extremely rewarding to work with our amazing staff.

Prior to the pandemic the vast majority of our work was face to face, which then presented huge difficulties with Covid-19.

We are a national clinic so we have patients travelling many hours to see us, often via public transport. Very swiftly we had to find a new way to deliver our service.

Dr Glidden, who has been Clinical Lead since January and has worked at the centre since 2014, said the majority of people were moved on to video consultations.

The centres support service was increased to five days a week.

Currently, 1,400 people are receiving care at the centre and 2,500 people are waiting to be seen.

There is a waiting list which is common to all seven transgender health centres in England, said Dr Glidden.

We tend to be talking about three years, it is our biggest area of concern and one of our clear priorities, he said.

Although gender-affirming surgery was postponed during the pandemic, Dr Glidden said activity levels at the centre were the exact same as pre-Covid times.

He said he is extremely hopeful that surgery can be restarted as soon as possible.

Each persons treatment programme is individualistic but can include cross sex hormone treatment, androgen blockade, voice therapy, facial hair removal, gender-affirming surgery and support.

Dr Glidden said some patients say visibility and acceptance has improved, but others say there are ongoing challenges in healthcare, life and society.

Nat Thorne, a PHD student who works at the Notts Trans Hub, praised the clinic for its work during the pandemic.

But they said long waiting lists have a huge impact on trans people.

Nat, who is currently looking into the mental health of non-binary people with the University of Nottingham and uses data from the transgender clinic, said: It is amazing that they managed to keep appointments going via Zoom as it was a massive worry in the community about the ever-growing waiting list.

It might be at four or five years by now. But everyone at the clinic is great, they are happy, positive people. We want to sing their praises because they are awesome.

Nat, 42, who has published three papers with the university, said there is a lot of nervousness when people first visit the clinic.

But they said: The way trans people have been treated generally isnt brilliant. But people come away from the clinic with a positive attitude, people feel listened to.

Go here to see the original:
Meet the man behind Nottinghams 'amazing' transgender clinic with a three-year waiting list - Nottinghamshire Live

The North American Menopause Society (NAMS) 2020 Conference starts September 30, and four different panels will emphasize the latest research on therapy for hot flashes and night sweats.

As many as 75 percent of North American women experience the disruption and discomfort of menopause-related hot flashes, or vasomotor symptoms (VMS). These usually persist for six months to two years. Some women, however, report experiencing hot flash symptoms for 10 years. For a small minority, they never go away.

RELATED: Coping With Hot Flashes and Other Menopausal Symptoms: What 9 Celebrities Said

It is important to develop new therapies for hot flashes, because we know that one size does not fit all for any type of therapy.We have used the same hormonal therapies for the last several decades and are developing an understanding that not all estrogens are alike, and different formulations and routes of administration are associated with different risk/benefit profiles. Developing new treatments will expand the choices available to women for management of what can be long-lasting and very bothersome symptoms for some women, says Stephanie S. Faubion, MD, MBA, the medical director of NAMS and the Penny and Bill George director at the Center for Women's Health at the Mayo Clinic in Rochester, Minnesota, and Jacksonville, Florida.

Here are the top hot-flash treatment takeaways from this years conference.

Nonhormonal options, such as SSRIs, SNRIs, gabapentin, oxybutynin, and clonidinealready exist;Susan D. Reed, MD, MPH, of the department of obstetrics and gynecology at the University of Washington School of Medicine in Seattle, told Everyday Health that she will discuss the efficacy of other drugs that target the KNDy neuron complex (estrogen-sensitive neurons in the hypothalamus) at this year's meeting. During menopause, estrogen levels decrease dramatically, which causes the KNDy neurons to be hyperstimulated, spilling over and having an adverse effect on the adjacent thermoregulatory center.

The result? Hot flashes and night sweats. Currently, the FDA hasnt approved any therapies that target KNDy neurons for use for hot flashes. But there are drugs that target KNDy that are now under development for VMS treatment. So far, results have been very promising.

RELATED: Treatments for Menopausal and Perimenopausal Symptoms

Estrogen therapy has always been complicated its benefits also come with risks. Experts have been searching, without much success, for selective estrogen receptor modulators (SERMs) that provide the benefit with minimal risk of breast cancer, stroke, blood clots, or heart attack.

Hugh S. Taylor, MD, at the department of obstetrics, gynecology, and reproductive sciences at Yale School of Medicine in New Haven, Connecticut, will present data about a new approach that is developing two fetal estrogens with SERM-like properties, called estriol and estetrol, which are different from the commonly used estradiol. Estetrol has been shown to decrease VMS intensity and frequency while providing benefits to the cardiovascular system. Estriol can also lessen some of the bad effects of estradiol. Researchers are still exploring this possible breakthrough in hormonal therapy.

RELATED: 10 Ways to Beat Menopausal Belly Fat

In 2015, NAMS provided a position statement on nonhormonal management of hot flashes. Janet S. Carpenter, PhD, RN, the Audrey Geisel Endowed Chair in Innovation and an associate dean of research at the Indiana School of Nursing in Indianapolis reviewed research done since then and will confirm the recommendations as still relevant:

RELATED: Menopause Experts Issue New Guidelines for Treating Vaginal and Urinary Symptoms

For a panel on nonhormonal management of menopause, Catherine Hansen, MD, of the Empowered Womens Circle in Houston, will report that while standard treatment is menopausal hormone therapy (HT or HRT), many women cannot tolerate HT or wish to avoid using it, yet arent fully informed about nonhormonal treatment options. This may lead them to use unproven, ineffective, or dangerous therapies. Dr. Hansen urges healthcare practitioners to educate themselves and their patients on appropriate nonhormonal care. Women should consult with their physicians before trying any new therapies, and it is best to follow plans that are appropriate for their individual and unique needs. What works for one woman may not work for another, and in fact, may be detrimental.

RELATED: 7 Fun Ways to Move More at Midlife

Dr. Faubion concludes that the important takeaways from these panels are: There are options out there for treatment of hot flashes. The only nonmedication therapies that have good evidence to support them for hot flash management are cognitive behavioral therapy and hypnosis. No over-the-counter herbs or supplements have been proved effective for hot flash treatment. At this time, hormone therapy is still the most effective option, and the benefits typically outweigh the risks for most symptomatic women under the age of 60 and within 10 years of menopause onset.

RELATED:Menopause and Sleep News: NAMS 2020 Addresses 5 Key Issues; Sex and Sex Drive in Midlife: News From NAMS 2020

Follow this link:
Menopausal Hot Flash Treatment Options Expand - Everyday Health

Amy Coney Barrett, the Trump administrations supreme court nominee, publicly supported an organization in 2006 that has said life begins at fertilization. It has also said that the discarding of unused or frozen embryos created in the in vitro fertilization (IVF) process ought to be criminalized, a view that is considered to be extreme even within the anti-abortion movement.

The revelation is likely to lead to new questions about how Barretts personal views on abortion may not only shape reproductive rights in the US for decades to come if she is confirmed by the Senate, but how her appointment could affect legal rights for women undergoing fertility treatment, as well as their doctors.

In 2006, while Barrett worked as a law professor at Notre Dame, she was one of hundreds of people who signed a full-page newspaper advertisement sponsored by St Joseph County Right to Life, an extreme anti-choice group located in the city of South Bend, which is in the region know as Michiana.

The advertisement, which appeared in the South Bend Tribune, stated: We, the following citizens of Michiana, oppose abortion on demand and defend the right to life from fertilization to natural death. Please continue to pray to end abortion.

The statement was signed by Barrett and her husband, Jesse.

In an interview with the Guardian, Jackie Appleman, the executive director of St Joseph County Right to Life, said that the organizations view on life beginning at fertilization as opposed to the implantation of an embryo or a fetus being viable did have implications for in vitro fertilization, which usually involves the creation of multiple embryos.

Whether embryos are implanted in the woman and then selectively reduced or its done in a petri dish and then discarded, youre still ending a new human life at that point and we do oppose that, Appleman said, adding that the discarding of embryos during the IVF process was equal to the act of having an abortion.

Asked whether doctors who perform abortion ought to be criminalized, she said: We support the criminalization of the doctors who perform abortions. At this point we are not supportive of criminalizing the women. We would be supportive of criminalizing the discarding of frozen embryos or selective reduction through the IVF process.

Appleman said the organizations views reflected a mission to create a culture of life and love in which every child is protected by law.

The White House deputy press secretary, Judd Deere, said in a statement to the Guardian: As Judge Barrett said on the day she was nominated, A judge must apply the law as written. Judges are not policymakers, and they must be resolute in setting aside any policy views they might hold.

The White House also pointed out that in her role as an appellate court judge in the seventh circuit Barrett had declined in July to stay the execution of Daniel Lewis Lee, a white supremacist convicted killer. Barretts decision in that case apparently showed a willingness to contradict her personal stated support for all life from fertilization to natural death.

Barretts public embrace of a strict anti-choice position will nevertheless fuel concerns of progressives and pro-choice Americans about what the 48-year-old judges confirmation to the supreme court will mean for abortion rights once conservatives gain a 6-3 majority on the court.

For years, mainstream anti-abortion activists have avoided including discarded embryos created in the in vitro fertilization process in their crusade to protect every embryo, in part because seeking to curtail IVF treatment would be very unpopular. In Alabama, which has passed a near-total ban on abortion, embryos created through IVF are excepted from the law.

But the issue has gained resonance with some fringe groups who have sought to give fertilized eggs a constitutionally protected right to life.

Dov Fox, author of Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law, said that if such a movement ever succeeded it could have the potential to prop up restrictions on fertility treatment.

For example, by banning IVF procedures that would involve freezing, destroying or donating for research any embryo a woman doesnt implant all at once, despite the health risks associated with high-order pregnancies and the hormone drugs required to extract eggs multiple times, he said.

Pro-choice advocates in South Bend described St Joseph County Right to Life as extreme, with a history of supporting super intimidating protests at the one facility in South Bend that provides abortion services.

The group was established in 1972 and has said its mission is to save children, women and men from the devastating effects of abortion and euthanasia. While it publishes a full-page advertisement every year, to mark the passage of Roe v Wade, Barretts name did not appear in any other ads that the Guardian found after 2006.

On its website, Right to Life said it focuses on outreach, advocacy, education and prayer and said it experienced a great victory in 2015 when it shut down South Bends only abortion clinic at the time, making our community free from an abortion clinic for the first time in decades. Three years later, a new clinic that provides abortions via pill up to 10 weeks was opened following a difficult campaign by pro-choice advocates.

Right to Life has said the opening of the new abortion business, a clinic called the Whole Womans Health Alliance, had led it to a doubling up on our efforts. We are closely monitoring these threats and executing fierce strategic plan to protect innocent human life at all ends of the spectrum.

Amy Hagstrom Miller, the president and CEO of Whole Womans Health Alliance, said the clinic in South Bend had direct experience with the Right to Life group, which among other anti-choice groups has used the clinics name and likeness in Facebook campaigns to arrange protests.

Clinics like Whole Womans Health Alliance face a number of barriers to treating patients in Indiana, Hagstrom Miller said, including rules that force patients who receive a non-surgical abortion to make two visits to a clinic: including for a mandatory ultrasound and counseling. The clinic sees patients only twice a week, and on those days the clinic is inundated with upwards of 70 protesters a day, she said.

Continued here:
Revealed: Amy Coney Barrett supported group that said life begins at fertilization - The Guardian

The group action involves a public awareness campaign, petitions and calls to MPs. They also plan to write an international open letter to the worlds governments.

Dr Gareth Davies, PhD (Medical Physics), Imperial College, London, says the UK governments recommendation of 400 IU daily of vitamin D is 10 times smaller than the group believes is necessary during this global pandemic. Those in the alliance believe that 4,000 IUs daily should be sufficient to ensure a healthy immune response in most people, with some in the group advocating a short course of up to 10,000 IU in cases of severe deficiency.

BetweenMarch to July 2020, Dr Davies has been working full time as a coronavirus research scientist, and has continued part-time thereafter. Much of his research has been around this vitamin. He says much of the confusion around vitamin D stems from the fact it is so poorly understood, firstly due to the fact it isnt actually a vitamin but asteroid pre-hormoneproduced in the skin in strong sunlight which is then converted into an active hormone by the liver and kidneys.

For most people, the idea that a simple over-the-counter vitamin can actually help fight a pandemic is so preposterous and I think this is largely due to the fact it is referred to as a vitamin when its not; it is an essential hormone which the immune system requires in order to function adequately.

Dr Davies explains that whilst research around this hormone first centred around the avoidance of rickets, our knowledge of the health benefits of this hormone are now far more far ranging and we now understand that it is a key component to the function of our immune system.

Dr Davies argues that much of the confusion and scepticism around the research into vitamin D, immunity and COVID-19 is due to the fact that research will often show a correlation and this is not seen to be causation. But Dr Davies disagrees with this conclusion.

Correlation isnt always causation but that word always is critical because sometimes and often correlation is causation. Most doctors wrongly think clinical trials are the only way to infer cause, but we can actually do this more effectively by analysing large data sets using modern techniques.

He and two collaborating doctors, published a preprint of their research in May, drawing on methods from Physics, Data Science and Artificial Intelligence in which they conclude that vitamin D deficiency causes severe COVID19 disease in response to the Sars-Cov-2 virus. Their two part analysis looked at 1.6 million data points of deaths and recoveries from 240 global reporting locations.

In June, the UK government ordered an evidence review into vitamin D and COVID-19but Dr Davies says the scientific community was up in arms following the NICE report.

Our paperwas one of just 13 preprints acknowledged by the NICE evidence review - but was listed in an appendix of preprints excluded due not yet being peer-reviewed. Peer-review takes up to a year in normal conditions and though hundreds of studies had been published, very few had been peer-reviewed.

NICE reviewed only five papers, four for the hypothesis and one against, ignoring the hundreds of other pre-print studies on SARS-CoV-2 and vitamin D, and thousands of studies published on prior coronaviruses and vitamin D.

In a fast moving global pandemic such as this when so much new research is being carried out, surely they should look at the newest research?

Speaking about concerns around overdosing, Dr Davies says he cant understand why that concern would outweigh the urgent concern of the pandemic.

People make this hormone when their skin is exposed to the sun. If there is danger of people overdosing on this hormone then where are those people and why arent we overdosing when we spend too much time in the sun? Coronavirus has killed one million people and governments are concerned about vitamin D overdosing!"

If vitamin D levels are high, the innate immune system is strong, explains Dr Davies. This is the first line of defence the body employs when a pathogen first invades. In many cases, the innate immune response can entirely deal with an invasion before it takes hold.

Its also involved a health adaptive immune response. This is a slower response where the body begins to make antibodies that specifically target the invading pathogen if it fails to control it via innate immune response.

Dr Davies points out theres a very specific reason this hormone is important with the COVID-19 virus, due to the mechanism by which it enters our cells.

It targets a protein spike on cell surfaces called ACE2 which is part of something called the renin-angiotensin system or RAS. Among other things, the RAS regulates blood pressure and inflammatory response. To use a metaphor, its like an engine with an accelerator and a brake. To tackle an infection the accelerator is pressed to ramp up inflammatory response to deal with the invading pathogen, but the brake also is depressed to keep things under control.

When the invasion is dealt with, the accelerator comes off and the brake brings everything down to an idling state again. The ACE2 protein is the brake, but ACE2 is depleted as the virus replicates which effectively breaks the brake. With only an accelerator, the RAS quickly runs out of control leading to cytokine storm, out-of-control inflammation and the lungs fill up causing pneumonia. This is what kills people. Vitamin D helps here by keeping the accelerator under control by suppressing a mechanism further upstream that activates it.

We also know that the ACE2 receptors are normally invisible when the RAS is in its idle state, as they ACE2 receptors form a bound complex with another cell receptor. This complex comes apart during the inflammatory response when ACE2 is needed, but this also makes it visible to the virus. Vitamin D helps to keep the RAS calm so that ACE2 remains hidden.

The government says it has issued new vitamin D recommendations "to ensure that the majority of the UK population has satisfactory vitamin D blood levels throughout the year, in order to protect musculoskeletal health".

On it's NHS website, it states: "Recommendations refer to average intake over a period of time, such as one week, and take account of day-to-day variations in vitamin D intake.

"SACN also looked at possible links between vitamin D and non-musculoskeletal conditions, including cancer, multiple sclerosis and cardiovascular disease. Theydidn't find enough evidence to draw any firm conclusions.

"In spring and summer, most of us get enough vitamin D from sunlight on our skin and a healthy, balanced diet.

"However, SACN couldn'tmake any recommendations abouthow much sunlight people would need to get enough vitamin D because there are a number of factors that can affect how much vitamin D is produced in the skin. So the recommendations assume "minimal sunshine exposure".

"During autumn and winter (from October until the end of March) the sun isn't strong enoughin the UK to produce vitamin D. That meanswe have to rely on gettingit just from the food we eat.

"Becauseit's difficult to get enough vitamin D from food alone,many of us risk not getting enough. Taking a supplement helps to keep levels of the vitamin topped up during the colder months."

The NHS also advises people do not take more than 100 micrograms (4,000 IU) of vitamin D a day as it says this could be harmful.

Martin Hewison, PhD,Professor of Molecular Endocrinology andDirector of Education at theInstitute of Metabolism and Systems Research,The University of Birmingham, is an expert on the subject of vitamin D whoisn't part of the alliance.

He agrees the current UK recommendations for vitamin D intake are "extremely conservative" and provides further explanation around the confusion.

"400 IU/day (10 micrograms/day) is not meant to optimise vitamin D but it is simply a level that SACN estimated that most UK people can reach to avoid severe vitamin D-deficiency (serum 25-hydroxyvitamin D < 10ng/ml).

"However, we do not know what the optimal level of vitamin D is for good immune function because these studies have simply not been carried out."

He is currently working with UK researchers to explore a different, UK-focused, approach based on supplementation with 1,000 IU/day vitamin D. He admits this will be seen as a compromise by North Americans but suggests it is a realistic step forward for the UK.

That being said, he says he does understand the position of those recommending 4,000 IU daily.

There are two important questions yet to be answered, he says. "Is vitamin D protecting against actual COVID-19 infection in the general population?Does vitamin D improve prognosis once you are infected?

"The answer may be both but I am guessing that the requirements for vitamin D are different for these two facets of COVID-19. Possibly you need higher levels to protect once you are infected."

Four of the doctors and scientists involved in this campaign have created a webinar on the subject of vitamin D and immunity which they have shared with the public, press and government advisors.

This open letter's current signatory list includes:

Dr Gareth Davies PhD (Medical Physics), Imperial College, London, UK; Codex World Top 50 Innovator 2019.

Professor Barbara Boucher Medical Doctor (retired), Honorary Professor, Centre for Diabetes, Bart's & The London School of Medicine and Dentistry, Queen Mary University of London, UK.

Dr David Grimes Medical Doctor (retired), University of Manchester, UK.

Dr Helga Rhein Medical Doctor (retired), Sighthill Health Centre, Edinburgh, UK.

Professor Peter Cobbold Emeritus Professor, Cell Biology, University of Liverpool, UK.

Dr Joanna Byers Medical Doctor (MBChB, Birmingham), Dip Global and Remote Healthcare (Plymouth), MSc Occupational Therapy (Essex), UK.

Dr Linda Benskin PhD, RN, SRN; Independent Researcher/Educator for VHWs and Clinical Research, Education, & Charity Liaison for Ferris Mfg. Corp, Austin/Ft. Worth TX, USA.

Dr William B Grant PhD (Physics) University of California, Berkeley; Sunlight, Director at Nutrition, and Health Research Center, San Francisco, CA, USA.

Dr Ute-Christiane Meier Dr. Med. Habil., PhD (Oxon), Kings College, Institute of Psychiatry, London, UK.

Dr Ased Ali B.Sc.(Hons), MBChB, PhD, FRCS (Urol); Consultant Urological Surgeon and Honorary Clinical Lecturer, Mid Yorkshire Hospitals NHS Trust.

Dr Jaimin Bhatt MBChB, MMed(Surg), FRCSEd(Urol), FEBU; Consultant Urological Surgeon, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde.

Dr David Carman BSc (Microbiology & Biochemistry) MBChB, University of Cape Town, South Africa.

Dr Karl Pfleger PhD (AI/Machine Learning) Stanford; Biotechnology investor, San Francisco, CA, USA.

Professor Michael F. Holick PhD, MD; Professor of Medicine, Physiology and Biophysics; Director of the General Clinical Research Unit; and Director of the Bone Health Care Clinic and the Director of the Heliotherapy, Light, and Skin Research Center at Boston University Medical Center.

Professor Bruce W. Hollis PhD, Professor of Pediatrics, Biochemistry and Molecular Biology, Director of Pediatric Nutritional Sciences, Medical University of South Carolina, USA.

Professor Richard B Mazess Emeritus Professor, Medical Physics, University of Wisconsin, Madison, USA; Founder of Bone Care Intl who developed a vitamin D analog for the treatment of end-stage renal patients.

Dr Henriette Coetzer MBChB, Medical doctor, healthcare risk consultant and NHS Trust CSO, Somerset., MBChB, Medical doctor, healthcare risk consultant and NHS Trust CSO, Somerset.

Carole Baggerly Founder Director of GrassrootsHealth, a nonprofit vitamin D research organization with 48 senior international vitamin D researchers contributing to its operations.

Read the original:
COVID-19: Scientists raise the vitamin D alarm - NutraIngredients.com

Whether you want children in the future, are undecided, or want to preserve your options due to medical reasons, the decision to freeze your eggs has become far more accessible over the last decade or so. Numerous fertility clinics have opened up across the globe, not to mention the technological innovation behind fertility treatments, which has served to promote the process further.

However, theres still a lot of confusion as to what it actually entails, and a lot of debate over the success rates. Here, we speak to some of the experts in the field to clear up everything you need to know about freezing your eggs.

There are many reasons why someone might decide to freeze their eggs, and each decision is extremely personal and unique. One of the most common reasons is that a woman isnt ready to have children or hasn't met the right person, but knows she wants children one day. Another common reason is if a woman is scheduled to receive medical treatments that affect fertility like chemotherapy, and freezing eggs helps to preserve the chance of having children down the line. Others may be inclined to freeze their eggs because they havent decided on whether or not they want children, but want to remove any feeling of time pressure from their decision making process.

The egg freezing process is similar to a cycle of IVF, except the fertilisation and embryo transfer happens at a later date explains Dr Ippokratis Sarris, Director at King's Fertility. Initially a course of daily injections (usually 2 different medications, or sometimes 3) are self-administered by the woman. These aim to stimulate the ovaries to produce a number of growing follicles (fluid-filled sacs within which the eggs reside) and also to control the ovulation so that these eggs can be collected.

The daily injections continue for a couple of weeks, known as the stimulation phase. During this phase, ultrasound scans are performed every few days looking at the ovaries in order to monitor the progress of the growing follicles and occasionally a blood test to check hormone levels, says Dr Sarris. Once the follicles have grown sufficiently, and to a size where it is expected that a mature egg will be retrieved, a final maturation injection is given, followed by the egg collecting procedure two days later.

The collection procedure itself is carried out under anaesthetic (usually sedation, but sometimes local or general anaesthetic is used). Using ultrasound guidance, a needle is passed through the vagina wall, then into the ovaries, and into each of the follicles, explains Dr Sarris. The fluid from within the follicles is drawn out and taken to the laboratory. An embryologist will look at this under a microscope in order to retrieve the eggs. The eggs are then checked for maturity and frozen within a few hours after the procedure.

Theyre frozen using fast-freezing process called vitrification, and stored in specialised cryotanks. The tanks are constantly monitored electronically and maintained, and the eggs can remain there for as long as the patient requires them.

According to the experts, the number of eggs collected can vary from woman to woman. On average, around 10 eggs are collected with any treatment cycle, although this very much depends on a woman's age and her egg reserve, says Dr James Nicopoullos, Medical Director at the Lister Fertility Clinic. Some may be able to produce significantly more on an even cycle and unfortunately some less, with the key being the investigations we do prior to this to help us council the patients as to what to expect and whether it is the right thing for them.

The procedure usually lasts 20-30 minutes, and after 1-2 hours of recovery, the woman can go home, says Dr Sarris. There might be a small amount of spotting from the vagina, and occasionally discomfort over the lower abdomen. However, simple pain relief medication (such as paracetamol or ibuprofen) is usually adequate in controlling it. The woman should be able to return to normal activities by the next day, and the period should arrive within the next 2 weeks. After that, the body should be back to normal and all the effects of the hormones should have passed.

Its possible to have the egg fertilised with sperm before freezing, making it a frozen embryo - however, there are many things to think about before doing so. My recommendation to any single woman would always be to freeze eggs initially for fertility preservation, says Dr Nicopoullos. The key with egg freezing is to give women reproductive choices and should she want to have a family with a future partner, having these eggs frozen will allow them to be thawed and fertilised with his sperm. If however she freezes embryos, i.e. fertilises her eggs with donor sperm before freezing, she won't have this option available to her.

Dr Sarris raises another key consideration; The downside is that the embryo legally belongs to two people (whoever provided the egg and sperm gametes), whereas, the egg just belongs to the woman and she can decide how it is used entirely independently.

The current legal time limit that an egg can be frozen for is 10 years unless theres medical reasoning to extend it, for example, if the woman was undergoing cancer treatment at a young age. There are current calls for the government to extend this limit.

According to Dr Sarris, when a patient wants to use their eggs, they effectively need to resume the process of the original cycle of IVF which stopped at the egg collection stage. The egg is thawed and fertilised by the sperm, he says. If the egg is successfully fertilised, it then becomes an embryo which is grown in the lab over the next few days and either be put back into the womans womb or it can be frozen again (this time as an embryo).

In order for a woman to have the embryo transferred into her womb, it has to be done in an embryo transfer cycle. This can be done in two ways, either the clinic will monitor the womans natural cycle and transfer the embryo at an appropriate time after ovulation, or the clinic can recreate a natural cycle by prescribing certain medicines that prepare the lining of the womb for the embryo to implant.

According to Dr Nicopoullos, the implantation process is very quick and no more invasive than a cervical smear test.

Success rates vary dramatically based on multiple factors, including the womans age at the time of egg collection (the younger the eggs, the higher the success rate), and her general health. Success rate of frozen eggs remains under some debate, says Dr Nicopoullos, but theres increasing research suggesting that success rates of using a frozen embryo are as similar to using a fresh embryo.

Dr Sarris explains that if the eggs are frozen at a clinically optimum age then the chances of success will be higher. However, it should be noted that obstetric (pregnancy) complications increase with a womans age. In addition, success is also dependent on how technically proficient the clinic is that freezes and thaws the eggs. Overall, he says the absolute chance of an egg giving a baby can vary from as low as 1% per egg to 5-6% per egg.

Lord Robert Winston, professor of fertility studies at Imperial College London and expert on egg freezing and IVF has publicly warned that success rates can be misleading. Speaking on BBC Radio 4 Todays programme, Lord Winston described the process as a very unsuccessful technology with a success rate of around 1%. However, he later clarified that he was referring to the number of live births, rather than the number of pregnancies. Sometimes, when a clinic gives a success rate, they are actually referring to the number of successful implantations into the womb (and subsequent pregnancies) rather than the live birth rate. The distinction between the two definitions of success can result in vastly different figures.

According to The Human Fertilisation and Embryology Authority, in 2015, 2% of all thawed eggs ended up as pregnancies and 0.7% resulted in live births.

The average cost for one round of treatment is between 3500 to 4500, and there's usually an annual fee for storing the eggs of around 200 to 400 depending on the clinic. If you are receiving medical treatment that affects your fertility, you may be able to get egg freezing on the NHS.

Its up to the woman what happens to her eggs if she no longer wants to continue freezing them. They can either be discarded or donated to medical research.

Original post:
Your Ultimate Guide To Egg Freezing From The Experts - GLAMOUR UK

Youve started your day with a cup of coffee for as long as you can remember. But maybe the caffeine doesnt work its magic like it once didor maybe its actually too powerful these days. Its no surprise your coworkers green tea is looking more appetizing every week. But is there that big a difference health-wise between the two drinks? We called on Dr. Felicia Stoler, DCN, a registered dietitian, nutritionist and exercise physiologist, to settle the green tea vs. coffee debate once and for all.

RELATED: Why You Shouldnt Drink Coffee on an Empty Stomach, According to a Nutritionist

Theyre both very different in terms of structure, flavonoids and antioxidants, says Stoler. The main caveat for both drinks is really their caffeine contentand how your body personally reacts to it. For instance, if you have no side effects from consuming caffeine but have acid reflux, green tea might be the better choice for you. If you literally hate the taste of green tea but coffee makes you jittery, its safe to stick to the java and cut back or use a mix of decaf and regular grounds. The TLDR: Theyre both fine to drink on the regularits just a matter of choosing whats best for your body and needs. Both [drinks] naturally contain caffeine, but there are decaffeinated versions available. I actually think if people consumed both, that would be great," says Stoler. "[It will] add some variety to the types of antioxidants and phytonutrients that you receive."

Lets face it: Most of us dont drink coffee every day for our health. Its typically for the caffeine boost, which we count on to drag us out of dream mode (and um, bed) and into real life every morning. Wed guess most green tea drinkers are in it for the energy boost too, though it has less caffeine. And the fact is, its tough for scientists to conclusively narrow down the perks or pitfalls of either drink. The challenge with the research in humans is that its impossible to do longitudinal studies on [coffee or green tea] to isolate the benefits or harm without other confounding factors, says Stoler. So, what do we know for sure?

Coffee, once colloquially thought to wreak havoc on the heart, is actually healthier than you may realize (before you add your caramel syrup and creamer, that is). Coffee is rich in antioxidants, which can help protect against type 2 diabetes, Parkinsons and certain types of cancer. Some people also swear that coffee helps keep their bowel movements regular. Coffees caffeine content is great for times when you need a short burst of energy and focus, say before you hit the gym or give a big presentation at work.

Green tea is better for mellow relaxation and a subtler energy boost (it kills the 3-oclock slump like a charm). Packed with cancer-fighting polyphenols, it can help burn fat, lower cholesterol and boost your metabolism. It can help fight against potential diseases like dementia, Alzheimers and Parkinsons, as well as reduce your risk for heart attack or stroke. Green tea is loaded with antioxidants that help your body detox, slow aging and combat inflammation. Most notably, green tea has a ton of L-theanine, an amino acid that boosts dopamine and reduces anxiety. It may help you relax so well during the day that your quality of sleep might actually improve.

Stoler also notes that both beverages are solid ways to stay hydrated. For people who don't like plain water, drinking coffee or green tea are a great way to increase fluid consumption.However, if youre drinking either with lots of added ingredients (milk, cream, sweeteners, syrups, etc.), then its an easy way to add unnecessary calories.

Both the main pro and con to each of these beverages is caffeinethe side youre on just depends on your bodys reactions to it. Nobody wants a rapid heart rate or to be kept up all night, says Stoler. Caffeines consequent effects are actually why some experts dont recommend having a cup of joe first thing in the morningespecially women. Coffee increases cortisol, aka the stress hormone that helps regulate your energy and alertness throughout the day. Cortisol is naturally high in the morning, so giving yourself an extra dose when you wake up can blunt its production and get your natural cycle out of whack. In fact, some studies show that it can cause you to naturally produce more cortisol than you need. That can negatively impact your ovulation, weight and hormones over time.

If youre drinking coffee first thing in the morning and on an empty stomach, heres why you shouldnt: Coffee stimulates acid production in the stomach (if youre prone to GI issues or have GERD, odds are you already learned that the hard way). Neutralizing your stomach acid (and that of the coffee) with a calcium-rich breakfast, like yogurt and almonds, can save you a lot of discomfort down the line. Other potential downsides to drinking coffee may include reduced bone density, an increase in cholesterol and higher risk for heart diseasebut the studies are sparse and the results are all in all pretty inconclusive.

Green tea, on the other hand, is easier on the gut than coffee and pretty low-risk all around, unless you have a history of kidney stones. Green and black tea have high levels of oxalates, which can lead to the formation of more stones (though its pretty rare). Other downsides include stained teeth after long-term consumption, which coffee can also cause, and weakened iron absorption. Tanins, an antioxidant in tea, can interfere with and reduce how much iron your body actually absorbs in a meal.

It all comes down to the caffeine. If youre switching from green tea to coffee, you might notice youre a little more jittery than usual. But switching from coffee to tea might give you symptoms of caffeine withdrawal. According to the Cleveland Clinic, cutting yourself off cold turkey can bring on headache, fatigue, concentration issues, muscle pain and even flu-like nausea. Withdrawal can last up to nine days; the more caffeine youre used to consuming, the more severe the withdrawal can be. Since were talking about switching from coffee to green tea, you wont be totally cut off from caffeine. Just try gradually reducing your intake (or substituting coffee with tea or decaf coffee) for a few days until you feel no symptoms.

If caffeine is still an issue even when youve switched to drinking mostly tea, think about switching to decaffeinated tea or coffee. Removing the caffeine and its effects from the equation actually sort of levels the playing field for both beverages. But you should know: Decaffeinated tea and coffee may not be as beneficial, because the decaffeinating process strips the drinks of some of their antioxidants. So, just decide whats best for you based on the reason why you drink coffee or green tea in the first place: the energy boost, the health benefits or the routine itself.

If youre hopping on the green tea train, drink it in the morning to wake up your brain, or during an afternoon slumpthe exact time doesnt matter much, because green tea actually *reduces* stress hormones like cortisol. And just for the record, you shouldnt drink either beverage right before bed. Green tea has a third of the amount of caffeine that coffee does (about 30 milligrams versus 96), but its still to be avoided in the evening, namely in the couple of hours before you hit the hay. Its still significant enough to trigger your hormones and adrenals, which translates to less sleep and late-night alertness.

Bottom line: Pay attention to how your body feels as you tweak your daily routine. Are you sleeping better? Feeling less anxious? Take note of what makes you feel your best and run with it. Hot or cold, both drinks are great to consume and have health benefits, says Stoler. So, instead of thinking of it as either/or, consider how to make both work in the day.

RELATED: Should You Drink Green Tea Before Bed? We Weight the Pros and Cons

Here is the original post:
Green Tea vs. Coffee: Which Is Better for You? We Asked a Nutritionist - PureWow

You wouldn't eat a food that shrinks your brain. You wouldn't drive a car that makes you sweat. You wouldn't buy a purse that worsens PMS. So why are we all so cool with stress being just "a part of life"? It doesn't have to be. And if you reduce stress, you will be better for it. Because the impact stress has on your body is remarkableand hazardous. Read on to discover 30 more things stress is doing to your bodyand to ensure your health and the health of others, don't miss these Sure Signs You've Already Had Coronavirus.

1

Your head is more likely to throb when you're stressed, according to the Mayo Clinic, with a tension-type headache or even a migraine. And feeling under pressure is also likely to make your headaches worse.

2

Stress kicks your body into its fight or flight mode, ramping up the release of certain hormones and preparing you to deal with danger. The result can sometimes be hands that shake like maracas.

3

We're not kidding. When we're stressed, our body releases the hormone cortisol, and in limited doses, it can actually be beneficial. But studiesincluding one at the University of California at Berkeleyhave shown that chronic stress actually decreases the weight and volume of the brain.

4

Stress can increase the production of stomach acid, leading to that annoying reflux, as acid irritates the esophagus. And if you already suffer from chronic heartburn, stress can make it worse. A study of nearly 13,000 sufferers published in Internal Medicine discovered that nearly half reported stress as the biggest factor that worsened symptoms.

5

Stress gets us all riled up and causes hyper-arousal, making it difficult to fall asleep, stay asleep and making the quality of our sleep worse.

Recommendation: The National Sleep Foundation suggests a cooling off period before bed time, which allows the brain to wind down. Two hours should do it. Put your work away, turn off the TV and grab a book or listen to music.

Story continues

RELATED: Doing This Just Minutes a Day Helps You Sleep Better

6

When you're stressed, the muscles responsible for breathing tense up, making it more difficult to catch your breath.

Recommendation: If you begin to feel panicky and short of breath, start by exhaling deeply, emptying your lungs. You can also try breathing through your nose, which automatically slows your breathing.

7

If it seems like you're more likely to be sick when you're stressed, you may not be imagining it. Studies have shed light on the link between stress and sickness, finding that those living with chronic stress (such as unemployment or caregiving to a dementia patient) had a suppressed immune system that left them more vulnerable to the flu and a host of other illnesses.

RELATED: 20 Reasons Why You Keep Getting Sick

8

When we're under stress, our hearts beat faster to help blood reach our vital organs. Often it's harmless, but it may not be for those suffering chronic stress. One study from the European Society of Cardiology found that people with stressful jobsnurses or bus drivers, for examplehad a 48% higher risk of atrial fibrillation, a condition marked by an irregular, often rapid heart beat.

9

Stress has been shown to cause reproductive problems in both men and women. In one study published in Fertility and Sterility, researchers tested 274 women who were trying to get pregnant and found that those with higher levels of a particular enzyme in their saliva correlated to stress had a 12% more difficult time getting knocked up.

10

Erectile dysfunction is complicated and can have physical as well as psychological causes. Science, however, has shown over and over that stress tends to make the condition worse by releasing more adrenaline and causing exaggerated contractions of the muscles in the penis, keeping it from filling with blood.

11

Research has shown that various kinds of stress can wreak havoc on a woman's period, making it irregular or disappear altogether. And to make matters worse, the Eunice Kennedy Shriver National Institute of Child Health and Human Development studied 259 women and found that stress can also make PMS pain worse.

12

And it's true in both men and women. The causes, a study shows, can be both physical and psychological. Stress causes hormonal changes in the body, which aren't particularly conducive for getting it on. It also makes someone distracted, and when their mind is on something else, sex can take a back seat.

Recommendation: One way to break the no-sex cycle is to get more physical with your partner, according to the Gottman Institute. "It simply forces the body to go from stress to relaxation, if you allow this. Kiss your stressed out partner a little bit more and hug them for 20 seconds longer."

13

Stress gets your heart pumping faster and spikes your blood pressure. Not good. Usually, the response in temporary, a reaction to a particular stressful event. But chronic stress over long periods of time can cause inflammation in the arteries, which could lead to a heart attack down the road.

Recommendation: Try some good ol' fashioned exercise. Working out three to five times a week can reduce your stress and will make a difference long-term in lowering your blood pressure, according to the Mayo Clinic.

14

When you're stressed, your body behaves as if it's under attack, and your liver reacts by releasing more glucose into your bloodstream. Ongoing stress can lead to long-term sugar spikes, putting you at risk of type 2 diabetes, say experts.

15

Your gut has the most nerves in your body, this side of your brain, and stress can adversely affect your entire digestive system. The hormones released when you're stressed can interfere with digestion and harm the microorganisms living in your digestive tract. Cue indigestion, cramps, nausea and a whole host of other GI issues.

16

That tightening can cause back aches and other ailments.

Recommendation: Next time you're feeling stressed, reach for the walnuts. Researchers have shown that foods containing polyunsaturated fats, like the nuts, may help us deal better with stress.

RELATED: This Can Be the First Sign of COVID, Study Finds

17

Stress can lead to a dry mouth in several ways, say experts. Anxious people tend to breathe through their mouths, drying out the inside. The acid reflux associated with stress can also have an affect on the salivary glands and keep them from producing as much.

18

Chronic stress can leave your feeling zapped of energy. It could be the accompanying insomnia, or some theorize that it might have something to do with exhausting your adrenal glandthough a 2016 review of the research debunked that diagnosis.

19

We sweat more when we're stressed and we sweat differently, studies show. Anxiety causes sweat to be produced from the apocrine glands, which secrete a thicker, milkier sweat than our eccrine glands. The downside: sweat from the apocrine glands tends to stink more.

20

Getting headaches is one thing, but actually altering your genetic code? Yep. Researchers at the University of Copenhagen have found that stress can switch on genes that weren't supposed to be switched on. "The consequence is that genes that should be turned off are now active and this may disturb cellular development, identity and growth," the researcher said.

RELATED: The Scariest New Symptoms of COVID-19

21

A study at Johns Hopkins concluded that long-term stress may affect the way that the genes controlling mood and behavior are expressed, leading a stressed-out person to be at a higher risk of depression. Tests on mice found that stress led to an increase in a protein produced by a gene called Fkbp5, which in humans has been linked to depression and bipolar disease.

22

"Are the strains and demands of modern society commonly exceeding human ability?" That's the question asked by the authors of this study of more than 17,000 working adults in Stockholm, Sweden. The scientists found that even mild stress can lead to long-term disability or an inability to work. Those who experienced mild stress were 70% more likely to collect disability benefits.

23

Watch out. Men who are moderately or highly stressed for a number of years were found to have a 50 percent higher mortality rate, according to the Journal of Aging Research. The good news is that two very stressful situations a year might actually be beneficial, teaching us to cope with adversity. Anything beyond that, however, and it might be an early grave.

24

There may be something to that cliche about stress eating. Researchers at University College London found that feeling stressed changes what we eat. Those under pressure didn't necessarily eat more, but they did reach for more sweet, fatty foods than usual.

Recommendation: If you're feeling stressed, be more aware of what you're eating and try to curb your consumption of junk foodno matter how much your brain is screaming that you need it. For food solutions, visit eatthis.com.

25

One of those areas of the brain that gets shrunken by stress is the hippocampus, which plays a big part in learning and memory. A 2018 study found that those with higher levels of the stress hormone cortisol did worse on memory tests, especially women.

26

Research has shown that periods of mild to moderate stress may actually help the brain to better encode memories and improve learning. For example, a college student freaked out about an upcoming midterm may actually retain the material better and ace the test.

RELATED: 38 Ways You're Treating Your Heart Wrong

27

In addition to generally suppressing the immune system, stress can lead to the growth of malignant cells, making a cancerous tumor bigger, says one study.

28

Children of parents with drinking problems face a greater risk of turning to booze after experiencing stressful situations, a University of Gothenburg study found.

Recommendation: "If alcohol relaxes you when you're stressed, then you should try to find other ways of calming yourself downrelaxation exercises, for example," the researcher suggests.

29

Tinnitus, that same kind of annoying ringing you get after, say, sitting through a Metallica concert, might just be induced by stress. One study by the Egypt's Minia University found that those suffering from chronic ringing tended to be more stressed. In short, "There is a direct correlation between duration of tinnitus and severity of stress."

30

It doesn't get more serious than that. Severe mental stress can bring on "sudden cardiac death," as medical professionals colorfully call it. In particular, suffering through a traumatic event, such as an earthquake or a war strike, can be so stressful that people literally keel over.

Recommendation: Don't worry. No one's ever died of a panic attack. If you're experiencing anxiety, don't miss these tips.

As for yourself: To get through this pandemic at your healthiest, don't miss these 35 Places You're Most Likely to Catch COVID.

Go here to see the original:
30 Things Stress Is Doing to Your Body - Yahoo Lifestyle

A study by a top American Hospital, Cleveland Clinic, shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits that are independent of weight loss. Thestudyis published in the October issue of Annals of Surgery.

This large observational study looked at 7,201 Cleveland Clinic patients in the U.S.: 1,223 patients with obesity and type 2 diabetes who underwent metabolic surgery (bariatric or weight loss surgery) were matched to 5,978 patients who received usual medical care. About 80 percent of the patients had hypertension, 74 percent had dyslipidemia (elevated triglycerides and cholesterol), and 31 percent were taking insulin to treat their diabetes.

Using different statistical models, the effects of weight loss were studied to identify the minimum weight loss needed to decrease the risk of death and of experiencing major adverse cardiovascular events, such as coronary artery events, cerebrovascular events, heart failure, kidney disease, and atrial fibrillation.

Following metabolic surgery, the risk of death and major heart complications appears to decrease after about 5 percent and 10 percent weight loss, respectively. Whereas, in the nonsurgical group, both the risk of death and major cardiovascular complications decreased after losing approximately 20 percent of body weight, saidAli Aminian, M.D., director of Cleveland Clinics Bariatric & Metabolic Institute, and lead author of the study.

Thisstudy suggests greater heart disease benefits are achieved with less weight loss following metabolic surgery than medical weight loss using lifestyle interventions. The study findings suggest that there are important benefits of metabolic surgery independent of the weight loss achieved, saidSteven Nissen, M.D., Chief Academic Officer of the Heart, Vascular & Thoracic Institute at Cleveland Clinic, and the studys senior author.

The groundbreakingSTAMPEDEstudy showed metabolic surgerys beneficial effects on blood glucose control. Since then, additional studies have observed health benefits other than weight loss following metabolic surgery. In fact, this research is a secondary analysis of a large study that showed weight-loss surgery is associated with a 40 percent reduction in risk of death and heart complications in patients with type 2 diabetes and obesity.

Researchers continue to study the physiological changes in the surgically modified gastrointestinal tract, the impact on hormone secretion and the microbiome. Those beneficial changes may contribute to the cardiovascular and survival benefits of metabolic surgery, independent of weight loss. More research is needed to better understand the underlying mechanisms for the health benefits of metabolic surgery in patients who have obesity and type 2 diabetes.

Here is the original post:
Cleveland Clinic Study Identifies Weight-Loss Threshold for Cardiovascular and Survival Benefits in Patients With Obesity and Diabetes - Al-Bawaba

In the last few years there has been more research around sexual function during the menopause transition in areas such as low libido or pain during intercourse, but very little specifically focused on how important sex is to women during this time, says Holly N. Thomas, MD, assistant professor of medicine at the University of Pittsburgh in Pennsylvania. Dr. Thomas is the lead author of research presented on the topic of the importance of sex in women as they age at the 2020 Virtual Annual Meeting of The North American Menopause Society (NAMS), which opened on September 28, 2020.

We were interested in looking at how womens ratings of how important sex was to them changes or stays the same as they move through the menopausal transition, says Thomas.

To find out the answer, investigators studied a total of 3,257 women from The Study of Womens Health Across the Nation (SWAN), all of whom completed 14 evaluations over 15 years. Visits included interviews, questionnaires, blood draws, and biometric measures such as body mass index (BMI), blood pressure levels, hormone levels, and depression symptoms.

RELATED: 10 Symptoms of Menopause and Perimenopause

Women were asked to rate how important sex was to them with the choices of not at all, not very, moderately, quite, or extremely.

Rather than look at averages of the women over time, investigators looked at trajectories within the cohort. This analysis technique allowed us to see if there are unique pathways that women can follow, explains Thomas.

If you just looked at averages of the group as a whole, it would look like how important sex is to women would go down for everyone, but what we actually found three distinct pathways women commonly follow when it comes to how much they value sex as they get older, she says.

RELATED: Masturbation 101: A Guide to Solo Sex for Women

For the largest group, about 45 percent of the women, sex did become less important to them as they went through their forties and fifties and early sixties, says Thomas. For 27 percent of the women, sex remained highly important to them throughout midlife, and for 28 percent of the women sex was not very important to them throughout the whole duration of midlife, from forties to sixties.

Its important to recognize not all women are going to follow the same pathway when it comes to sex at midlife, each woman has her own unique experience, says Thomas.

There were a few trends that Thomas and her team noticed.

These results show that its not necessarily true that sex becomes less important to all women at midlife and that its just an inevitable fact of aging, says Thomas.

RELATED: Menopause and Depression Is Strongly Linked

My takeaway was that we need to be more routinely asking women in midlife about their sexual function and whether there are barriers such as having pain during intercourse or if theyre having problems with low sexual desire thats bothering them, says Stephanie Faubion, MD, director of the Mayo Clinic Center for Womens Health in Rochester, Minnesota, and medical director of NAMS.

Sexual function is usually under addressed in women in general but certainly in women beyond menopause, adds Dr. Faubion.

RELATED:Sex Drug for Women Stirs Up Controversy in Medical Community

In general, women who have a good sex life before menopause have a good sex life after menopause, she says. This research indicates that if sex is important to a woman before menopause, its important after.

RELATED: Sexual Dysfunction in Some Women Can Occur Years Before Menopause, Study Says

Keep in mind that sex doesnt look the same with aging, says Faubion. We have to modify our expectations about sexual functioning as we get older. Sex may not be always be penis and vagina sex; I have that conversation often with my patients, she says.

As peoples bodies and health changes, including medical illnesses that can be experienced by both men and women, we may need to modify what we are doing, but nonetheless, sexual intimacy remains important to all people for as long as they live, says Faubion.

RELATED: What Is the Role of Intimacy and Sex in Overall Health?

About 30 percent or so of women in the United States report low libido or sex drive, and about 10 percent report being bothered or distressed by it, Brooke Faught, doctor of nursing practice and board-certified women's healthcare nurse practitioner, who is clinical director of the Womens Institute for Sexual Health in Nashville, Tennessee. Dr. Faught presented on sexual health, libido, and testosterone at the NAMS 2020 conference.

Having a low sex drive isnt automatically a reason for treatment; hypoactive sexual desire disorder (HSDD) is when women have a low libido and are bothered or distressed by it. If the patient isnt directly impacted or bothered by it and its not impacting their daily function, its not a true diagnosable condition, says Faught.

RELATED: The Facts About Sexual Desire Disorder (Low Libido) In Women and Men

Even when they are bothered by a lack of desire, many women put up with it rather than seek treatment; they think its a normal part of aging or something they should just deal with, she says.

One barrier that stands in the way of treating HSDD is the lack of an U.S. Food and Drug Administration (FDA)approved testosterone for women with HSDD, even though there is quite a bit of published research on how and when to use it, says Faught.

Faubion agrees, saying Testosterone is fairly well studied for sexual health in women and is effective in almost all areas of sexual function.

RELATED: Women Need Testosterone Formulation for Low Libido

The barrier that exists isnt lack of science or lack of interest, its the FDA, says Faught. The FDA has asked for more long-term data for using testosterone in hypoactive sexual desire disorder (HSDD) in women, potentially up to five years [worth], she says.

A study that would fulfill the FDAs request seems to be cost prohibitive for pharmaceutical companies, says Faught. I dont know of any specific product that is on the cusp of getting approval or seeking approval, which is unfortunate and frustrating, she adds.

There are options and guidance for how to use testosterone products for HSDD, says Faught. In 2018, the International Society for the Study of Womens Sexual Health (ISSWSH) published a process of care (POC) for the diagnosis and management of hypoactive sexual desire disorder (HSDD) in pre- and postmenopausal women, including guidelines for prescribing testosterone in postmenopausal women with HSDD.

A global consensus statement that was endorsed by several international medical societies including The International Menopause Society, The Endocrine Society, and the NAMS was published in The Journal of Clinical Endocrinology & Metabolism in October 2019. The statements purpose is to provide clear guidance on which women may benefit from testosterone therapy, as well as any potential risks.

The issue is that treating off-label can carry additional risk and expense for patients, says Faught. If I prescribe a testosterone product thats intended for men, I can prescribe it at a lower dose as is necessary, but because it isnt FDA approved for this use, usually insurance wont cover it. That could mean a cost of anywhere from $300 to $500, she says.

Compounding testosterone, a process where a pharmacist specifically makes the product from scratch may be cheaper, but then there is increased potential for human error as well as a lack of regulations, says Faught.

Probably the main reason there is no FDA-approved testosterone product for HSDD is that theres a lack of long-term safety data, says Faubion. For example, we dont know breast cancer risk, we dont know cardiovascular risk, she says.

The cardiovascular risk appears to be less of concern for women than it is for men taking testosterone, but the bigger question is breast cancer risk over time, says Faubion. This is because testosterone converts to estrogen inside the body, and so there is a question on whether that increases breast cancer risk, she says.

Ive used it in my practice and its effective for women, says Faubion. Yes, we still have questions about long-term safety and long-term efficacy, but for short-term efficacy and short-term safety, we have pretty convincing data; I think ultimately it probably will be approved for use in women.

RELATED:Menopause and Sleep News: NAMS 2020 Addresses 5 Key Issues;

Hot Flash Treatment News: 4 Takeaways From NAMS 2020

Go here to see the original:
Sex Life, Sex Drive, and Menopause: News from NAMS 2020 - Everyday Health

According to a recent market study published by Growth Market Reports (GMR), titled, Global Acromegaly Treatment Market by Product, End-user, and Region: Size, Share, Trends and Opportunity Analysis, 2017-2027, the market was valued at USD 1,304.4 Million in 2019 and is expected to grow at a healthy growth rate of 7.6% by the year 2027. The global acromegaly treatment market is anticipated to grow owing to rising prevalence of acromegaly especially in developed countries. Further, increasing awareness among the people for acromegaly, and rising number of clinical trials for acromegaly drugs are the factors which is expected to drive the growth of the global acromegaly treatment market.

The global acromegaly treatment market is fragmented based on product, end-user, and region. In terms of product, the market is segmented into somatostatin analogs, growth hormone receptor antagonist (GHRA), and dopamine agonist. On the basis of end-user, the market is divided into hospitals & clinics, and others. Based on region, the global acromegaly treatment market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, Asia Pacific is further segmented into, China, Japan, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific. The Europe region is further categorized into Germany, France, Italy, U.K., Spain, Russia, and Rest of Europe, and the MEA region is further divided into Saudi Arabia, South Africa, UAE, and Rest of MEA.

Request a free sample copy:https://growthmarketreports.com/request-sample/17

Acromegaly is one the rare disorders which is usually caused by excess development of growth hormone by the pituitary gland. This excessive growth hormone affects a patients internal organs and physical appearance. Acromegaly is mainly caused by benign pituitary tumor (adenoma); however, in rare cases acromegaly is caused by ineffective control of GH-secreting cells by hypothalamus. If acromegaly is untreated or not treated properly, it can lead to serious and life threating complication such as ventricular arrythmia and cardiomyopathy. To detect acromegaly doctors use diagnostic approaches such as blood test to measure the level of insulin-like growth factor or growth hormones and imaging of tumor through computed tomography (CT) scan and magnetic resonance image (MRI) scan. In acromegaly treatment some of the medications which are used are 90% effective in shrinking the tumor. However, the success rate for acromegaly treatment varies health, age, and medical history of the patient.

As per GMR industry analyst Vidya Jadhav, The Global Acromegaly Treatment Market is anticipated to witness significant growth during forecast period 2021-2027 driven by increasing prevalence and incidence of acromegaly across globe, rising awareness across developing economies, increasing initiatives taken by government to promote the awareness about this rear disease. Moreover, the increasing R&D, investments, and boom in clinical trials to develop new medication for acromegaly is expected to create lucrative opportunity during forecast period.

For More Information, Visit https://growthmarketreports.com/enquiry-before-buying/17

Request a free sample copy:https://growthmarketreports.com/request-sample/17

About Us:

Our reports are more than just research reports to us. They are tools that enable us to maintain long-term relationships with our clients whom we honor and cherish. Our clients business growth is integral for not only them but also us. This is what differentiates us from other market research companies.

At GMR, we provide our expertise and guideline for success. Our team of efficient and experienced researchers and consultants provide progressive market intelligence reports that are accurate, authentic, and in-depth. This empowers the clients to make well-informed decisions.

Moreover, we offer market intelligence studies, ensuring relevant and fact-based research across a range of industries including chemicals and materials, energy, automobile, healthcare, consumer goods, and technology. Our deep understanding of many business environments across industries such as those mentioned above allows us to deliver tailor-made reports.

Contact Us:

Alex MathewsHead of Business DevelopmentPhone No.: +1 909 545 6473Email [emailprotected]Website https://GrowthMarketReports.comAddress 500 East E Street, Ontario, CA 91764, United States.

See more here:
Global Acromegaly Treatment Market Expected to Reach USD 2299.4 Million by 2027 - The Daily Chronicle

Amanda French, co-founder & CEO at Emme

Amanda French, cofounder and CEO at Emme, is applying her medical device development background to solve the oral contraceptives' missed pill problem. After three years of building and testing its Bluetooth-enabled "smart case," which works with more than 100 birth control brands, it has launched.

When you miss taking a pill, the app automatically sends user-customized reminders. It notifies at-risk users when back-up contraception is needed. The app also allows users to track symptoms in the categories of "mood, body, sex, and flow" related to their menstrual cycles or hormones. When you track symptoms, you can see patterns as they pertain to pill habits. The data can be used to understand the effects specific birth control pills have on hormonal issues and help women and their doctors find the right pill in the right dose. But, like many female founders tackling women's health care, funding has been a challenge.

Emerging technologies have the possibility of improving health outcomes and reducing medical costs. Yet, a massive market is ignoredwomenwho make up more than 50% of the population. Stanford Biodesign's mission is to advance health technology innovation to improve lives everywhere. In 2016-2017, as a fellow at Stanford Biodesign, French and others focused on looking for and understanding unmet needs in the healthcare space.

"I was floored and disappointed at the lack of innovation that I was seeing in women's health, especially with their experience with the [birth control] pill," she exclaimed. According to Grandview Research, the U.S. contraceptive market size is expected to reach $7.2 billion in 2020.

French noticed a gap in the "pill experience." Oral contraceptives are nearly 100% effective in preventing pregnancies. However, "adherence is such a challenge," sighed French. More than half52% of women reported missing taking the pill. She had experienced this problem herself. Unfortunately, missing taking the pill leads to 1 million unplanned pregnancies in the U.S. each year. It also disrupts hormone balance, causing side effects such as bleeding, nausea, mood changes, and headaches.

Women are blamed for the problem"user error." "Education will fix the problem" is the most common refrain. Other health sectors are taking a more proactive approach. These sectors don't expect the patient to do better. They use technology to help. "I found it shocking that there is such a common pain point that was not being addressed by any innovative technology," said French.

In 2017, she and her co-founder Janene Fuerch, MD, launched Emme. The first couple of years were spent building the first version of the system and proving its efficacy using a rigorous national data sample. "We saw an 80% reduction in missed pills and 85% improved confidence and peace of mind," said French.

Finding funding was challenging. Women's healthcare is underfunded. "Male investors didn't see how they made money solving women's health problems," said Amy Millman, president of Springboard Enterprises, in a recent article I wrote. Recently, she launched the Women's Health Innovation Coalition to focus attention on gender-specific health. "There's been a lack of acknowledgment that women's health is a massive business opportunity that's worth investing in," said French. "Many investors told me women's health is a niche industry and the missed pill problem isn't one that could lead to a pain point worth solving and worth investing in.

"As someone who came out of the cardiovascular and hearing aid health spaces, I saw there was almost no technology being developed for women's health that could be used in the hospital, clinic, and home settings," said French. An initial grant of $100,000 came from Stanford Biodesign, Atlantic Pediatric Device Consortium, and VentureWell. The funding was used to provide scientific evidence of the effectiveness of Emme's system.

Being part of organizations that support budding entrepreneurs, and being comfortable introducing herself to industry movers and shakers and leveraging those contacts has opened doors for French. A case in point was meeting Deb Kilpatrick, Evidation Health CEO, MedTechWomen cofounder, long-time mentor at Stanford Biodesign, and advisory board member of the Ferolyn Fellowship. After hearing Kilpatrick speak at a MedTechWomen in 2016, French approached her. "Let's have coffee," she said.

The relationship built over time. "There's a misconception that the mentor is always helping the mentee," said French. It wasn't just her taking from Kilpatrick. French provided insights into the sectors she knew best and referred engineers when Kilpatrick was looking for talent. Kilpatrick became an advisor to Emme. She introduced Christine Aylward of Magnetic Ventures, which led the seed round of $2.5 million, which recently closed. Kilpatrick is now on the company's board as its first independent board member. Bolt led the pre-seed round. To date, Emme has raised $3.5 million.

Money wasn't the only challenge French faced. For the company, the coronavirus pandemic didn't just mean working from home. The team had to rethink how it would do extensive testing in-house and contract firms for design verification of the hardware. One of Emme's mechanical engineers built out a full design verification test setup in his kitchen.

Emme's components are sourced from around the world. The company had to rethink its material planning strategy, too. It ordered more components to ensure it had the parts in stock.

While Emme is focused on birth control pills to start, French recognizes the system's potential for ensuring that medication and even vitamins are taken. "That is certainly on our horizon," said French.

How will you build your network so you have access to the resources you need?

Read more:
Women Use Tech To Solve Womens Health Problems, A Market Men Ignore - Forbes

Following a balanced diet that incorporates healthy fats and high-fiber foods can help you manage your weight when you have PCOS.

Image Credit: mapodile/E+/GettyImages

There's a close but complicated relationship between weight and PCOS, or polycystic ovary syndrome. More than half of people who have PCOS are overweight, according to the Cleveland Clinic. The condition is a common cause of infertility and can also up a person's risk for heart disease and type 2 diabetes.

People with PCOS are also more likely to gain weight and often find it harder to shed extra pounds. But why is weight gain so common for PCOS and are there tactics to help maintain a healthy weight?

Does PCOS Actually Cause Weight Gain?

This is still a chicken-and-egg question: It's not clear if extra weight causes PCOS, if PCOS is the reason for the added pounds or if the relationship works both ways, per Johns Hopkins Medicine.

Here are some possible factors behind the connection between PCOS and weight gain.

If you have PCOS, it's likely that you'll have higher levels of androgens, the so-called "male" hormones such as testosterone. While everyone has androgens in their bodies, levels are generally elevated for people with PCOS compared to people with ovaries who don't have the condition.

This uptick in androgens not only contributes to weight gain but is also implicated in common PCOS symptoms such as irregular periods and unwanted facial hair (called hirsutism), per Penn Medicine.

Insulin resistance is a key part of the weight and PCOS relationship. This occurs when your body doesn't use insulin, a hormone made by your pancreas, the way it should. Normally, insulin takes sugar from foods you eat out of your bloodstream and deposits them into cells to be used as energy, according to the Mayo Clinic.

But with insulin resistance, sugar stays in your bloodstream and doesn't get stored in cells. Instead, "it's shipped off into fat," explains Libby Mills, RD, a national spokesperson for the Academy of Nutrition and Dietetics.

This is a risk factor for type 2 diabetes. Indeed, more than half of the people diagnosed with PCOS go on to develop type 2 diabetes before the age of 40, according to the Centers for Disease Control and Prevention (CDC). Insulin may also contribute to high androgen levels, per Penn Medicine.

Why Is It Hard to Lose Weight if You Have PCOS?

Many with PCOS do find it difficult to shed those extra pounds, says Jennifer Wu, MD, an ob-gyn with Lenox Hill Hospital in New York City. That may be due to insulin resistance as blood sugar is diverted into fat instead of being stored for energy.

Extra weight can also have psychological effects that double down on this difficulty. One is self-esteem. Symptoms like hirsutism and extra weight "can fold into emotional eating, which can compound the problem," Mills says.

Here's something we do know: Losing weight, if you need to, can help ease symptoms of PCOS such as irregular periods and infertility, per the Office on Women's Health. It can also reduce the risk of future complications like heart disease and type 2 diabetes.

"Typically the severity of PCOS symptoms increases as a person gets heavier," Mills says.

Again, science points to the role of insulin resistance. For people with PCOS, losing weight improved insulin resistance while also lowering blood sugar levels, body mass index, weight and belly fat, per a July 2020 meta-analysis in the Journal of Clinical Endocrinology and Metabolism. More fat around the middle has been linked with a higher risk of hypertension, heart disease and type 2 diabetes, according to the National Institutes of Health.

How Can You Manage PCOS and Your Weight?

There's no cure for PCOS so doctors rely on medications to relieve specific symptoms and, not surprisingly, lifestyle changes. High on the list of lifestyle changes: losing weight or maintaining a healthy weight.

"That's one of the first things we tell patients: Let's try to have you achieve an ideal body weight," Dr. Wu says.

Here are the strategies commonly used to help manage this condition:

There's no official (or unofficial) PCOS diet. Instead, patients are advised to follow the same type of balanced diet that all of us should be adhering too, with a couple of emphases added.

Exercise is important, too, with studies showing that it can affect waist circumference and body fat. "Physical activity has to be part of the weight-loss equation," Mills says.

Getting enough shut-eye is also a priority for weight loss. "When we don't sleep, it's a stressor to the body and can make it really difficult to lose weight," Mills notes.

Metformin is a diabetes drug doctors sometimes prescribe as PCOS treatment to help regulate blood sugar and insulin. Some people also lose weight with the drug, Dr. Wu says. One early (but usually temporary) side effect can be nausea, Mills says.

Talk to your doctor about whether any weight-loss medications would be beneficial. "It's certainly a topic of discussion if the person is really struggling," Mills says.

Gastric bypass surgery is a last resort for people with PCOS, Dr. Wu says. Evidence is emerging that these procedures can resolve problems like insulin resistance, according to a July 2020 study in Therapeutic Advances in Endocrinology and Metabolism.

Read the original post:
What You Should Know About How PCOS and Weight Are Connected - LIVESTRONG.COM

A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits that are independent of weight loss. The study is published in the October issue of Annals of Surgery.

Ali Aminian, M.D.

This large observational study looked at 7,201 Cleveland Clinic patients: 1,223 patients with obesity and type 2 diabetes who underwent metabolic surgery (bariatric or weight loss surgery) were matched to 5978 patients who received usual medical care. About 80 percent of the patients had hypertension, 74 percent had dyslipidemia (elevated triglycerides and cholesterol), and 31 percent were taking insulin to treat their diabetes.

Using different statistical models, the effects of weight loss were studied to identify the minimum weight loss needed to decrease the risk of death and of experiencing major adverse cardiovascular events, such as coronary artery events, cerebrovascular events, heart failure, kidney disease, and atrial fibrillation.

Following metabolic surgery, the risk of death and major heart complications appears to decrease after about 5 percent and 10 percent weight loss, respectively. Whereas, in the nonsurgical group, both the risk of death and major cardiovascular complications decreased after losing approximately 20 percent of body weight, said Ali Aminian, M.D., director of Cleveland Clinics Bariatric & Metabolic Institute, and lead author of the study.

Steve Nissen, M.D.

This study suggests greater heart disease benefits are achieved with less weight loss following metabolic surgery than medical weight loss using lifestyle interventions. The study findings suggest that there are important benefits of metabolic surgery independent of the weight loss achieved, said Steven Nissen, M.D., Chief Academic Officer of the Heart, Vascular & Thoracic Institute at Cleveland Clinic, and the studys senior author.

The groundbreaking STAMPEDE study showed metabolic surgerys beneficial effects on blood glucose control. Since then, additional studies have observed health benefits other than weight loss following metabolic surgery. In fact, this research is a secondary analysis of a large study that showed weight-loss surgery is associated with a 40 percent reduction in risk of death and heart complications in patients with type 2 diabetes and obesity.

Researchers continue to study the physiological changes in the surgically modified gastrointestinal tract, the impact on hormone secretion and the microbiome. Those beneficial changes may contribute to the cardiovascular and survival benefits of metabolic surgery, independent of weight loss. More research is needed to better understand the underlying mechanisms for the health benefits of metabolic surgery in patients who have obesity and type 2 diabetes.

Read the original:
Cleveland Clinic Study Identifies Weight-Loss Threshold for Cardiovascular and Survival Benefits in Patients with Obesity and Diabetes - Health...

If youre living with hypothyroidism, youre likely already familiar with the common symptoms, which can include fatigue and weight gain. But if youre a woman around the age of menopause which can range from 40 to 58, with the average onset at age 51 you may also experience identical issues, according to the North American Menopause Society (NAMS). So if youre in middle age, it can be hard to know whats really going on, and how to get relief.

Read on for what you should know about your menopausal years if you have hypothyroidism.

Menopause is a natural transition that women experience, and its the permanent end of menstruation. After a woman has had her final period and doesnt menstruate for 12 consecutive months, shes been through menopause, according to the NAMS.

During perimenopause the time leading up to menopause and menopause, hormonal fluctuations are common. This can even be when hypothyroidism develops in some women. One theory is that fluctuation in estrogen levels may increase inflammation, creating the ideal environment for development of autoimmune diseases such as Hashimoto's thyroiditis, which may lead to hypothyroidism, explains Cheryl R. Rosenfeld, DO, a spokesperson for the American Association of Clinical Endocrinologists, partner at North Jersey Endocrine Consultants, and adjunct clinical associate professor of medicine at the Touro College of Osteopathic Medicine in New York City. The drop in estrogen is what causes menopausal symptoms.

Hypothyroidism occurs when the thyroid gland does not make enough thyroid hormone. The most common cause is inflammation of the thyroid, but it may also be due to a number of other causes, including too much or too little iodine in the body, taking medications such as lithium, and inflammation of the thyroid, according to the American Thyroid Association (ATA).

Even if youve had hypothyroidism for a while, when you reach menopausal age, the lines between hypothyroidism and menopause can start to blur. Symptoms of hypothyroidism can be confused with symptoms due to the menopause transition, says Ekta Kapoor, MBBS, an endocrinologist in the Menopause and Women's Sexual Health Clinic at the Mayo Clinic in Rochester, Minnesota.

These same symptoms can include:

Rosenfeld cautions against using synthetic thyroid hormone medication to alleviate menopause symptoms in women with normal thyroid function. "While there is a great deal of overlap in the symptoms, if the thyroid blood tests are normal, it would be wrong to treat a person without thyroid disease with thyroid hormone or to increase thyroid hormone in a person with hypothyroidism to alleviate symptoms of menopause," she says. "Thyroid hormone is not a cure-all for symptoms it is a treatment for hypothyroidism."

If youre looking for a clue as to whats causing your issues, check your body heat hot flashes and night sweats are unique to menopause, says Dr. Kapoor. But there is an exception: Over-replacement with thyroid hormone can also cause hot flashes and night sweats, notes Kapoor. So work with your healthcare provider to ensure you are getting an appropriate amount of thyroid hormone treatment. If you are and youre still waking up sweating, thats a good indication that you are indeed experiencing menopause symptoms.

Hypothyroidism can worsen menopause symptoms. So rather than shrug off your symptoms, its important to maintain hypothyroidism treatment during menopause. Undertreated thyroid disease may cause increased cholesterol, leading to atherosclerosis and possibly heart attack or stroke, says Rosenfeld. In addition, hypothyroidism may cause high blood pressure, leading to similar heart complications. Overtreatment with thyroid hormone is also a known cause of osteoporosis, Kapoor adds.

Healthcare providers know to adjust thyroid treatment based on your current needs, and that includes during menopause. When estrogen levels drop at the time of menopause, people who are on levothyroxine to treat hypothyroidism may experience a change in their thyroid hormone needs, usually downward, says Rosenfeld. And conversely, hormone therapy which is commonly used to treat menopause symptoms can necessitate the opposite. If a woman treated with thyroid hormone starts estrogen, her dose of levothyroxine may have to be increased, says Kapoor.

A study published in December 2018 in the journal Climacteric stated that the decision to use hormone therapy for menopause should be individualized in women with thyroid disorders such as hypothyroidism.

The bottom line: Work closely with your healthcare provider so your thyroid symptoms and your menopause symptoms can be kept to a minimum.

Original post:
What to Know About Menopause if You Have Hypothyroidism - Everyday Health

A year and a half after landing a $70 million Series C round, Shanghai-based InventisBio has more than doubled that amount in a hefty Series D.

Merck vet Yaolin Wang launched Inventis from scratch back in 2015. In 2017, the biotech had 7 staffers, a $19 million Series B and an ambitious two- to three-year timeline to its first approval. While the company has yet to snag a regulatory OK, its lead candidate targeting EGFR T790M mutations is currently in registrational trials as a first- and second-line treatment in non-small cell lung cancer.

Those trials, the company said, are progressing smoothly.

The $147 million Series D will be used to give the biotechs gout and breast cancer drugs a big push.D-0502, an oral selective estrogen receptor degrader (SERD) and estrogen receptor antagonist, is currently in Phase I development for hormone receptor-positive breast cancer. D-0120 is in Phase I for gout. Wang plans to launch both candidates into Phase II trials in China and the US.

The D round was led by Hillhouse affiliate GL Ventures. Returning investors Lilly Asia Venture, OrbiMed Asia, Pudong Innotek, AdvanTech Capital and CMB International chipped in, as well as new investors Qiming Venture Partners, Janchor, AIHC Capital, Matrix Partner China, Dyee Capital and E Fund Capital.

In 2017, upon announcing its Series B, InventisBio also said it was developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. A year later, the biotech agreed to out-license its NSCLC candidate to Betta Pharma for 230 million ($33.7 million). The deal gives Betta Pharma exclusive commercialization rights in China, while InventisBio keeps its options in other regions of the globe.

InventisBio is committed to developing first- and best-in-class innovative drugs for cancer and other major diseases, Wang said in a statement.

More:
InventisBio reels in $147M to push gout and breast cancer drugs along - Endpoints News

September is Polycystic Ovarian Syndrome Month, and while this is a condition that is hard to treat, as hormones go into overdrive and create symptoms throughout the body, there are dietary ways to alleviate some of the worst symptoms, and most of the foods doctors recommend are plant-based.

PolyCystic Ovarian Syndrome, also known as PCOS, is one of the most common endocrine disorders among women of childbearing age. In the United States, 1 in 10 reproductive-age women will experience PCOS in their lifetime.

The syndrome is thought to be caused by hormonal imbalance, which is linked to metabolism problems that may affect a woman's overall health, reproductive health, and appearance. Specifically, PCOS patients are likely to have high levels of androgens, or testosterone, whichin turncan lead to symptoms such as excess body hair or Hirsutism, and cystic acne, irregular or painful menstrual cycles, orsmall cysts on the ovaries, that only show up on an ultrasound. Moreover, 80 percent of PCOS patients tend to be overweight or have excess fat around the belly, which leads to difficulty processing the hormone, insulin. Because of the excess weight associated with the condition, PCOS patients can often have higher rates of sleep apnea, joint pain, and trouble with conceiving.

While there are medical and pharmaceutical treatment options to manage symptoms, lifestyle changes are key to long-term success when treating PCOS, and dietary changes are often recommended as the first intervention.Dr. Shebani Sethi Dalai, MD, MS, the Founding Director of Stanfords Metabolic Psychiatry Clinic, and Silicon Valley Metabolic Psychiatry advises that patients need to focus on the connection between metabolic function and mental health as well, to help come up with a strategy for dealing with PCOSby reducing inflammation and insulin resistance through food choices.

Research shows that healthy eating and physical activity can help manage symptoms of PCOS, says Dr. Sethi Dalai. This includes blood sugar and insulin resistance, which we often see in PCOS and is a cause for infertility in young reproductive-age women.

Food choices matter when dealing with PCOS, according to astudy published in the International Journal of Reproductive Medicine, which examined the relationship between a Healthy Eating Index (HEI) and PCOS. Researchers found that the consumption of whole grains, plant proteins, and fewer refined grains was associated with a lower risk of PCOS in women ages 20-40. Here are the six best foods to eat if you are dealing with PCOS.

Green leafy veggies like broccoli, brussels sprouts, and cabbage are filled with tons of magnesium, which are incredibly helpful in tackling insulin resistance, seen in many individuals with PCOS. One study published 2019 in Food Science & Nutrition found that increasing dietary fiber and magnesium may assist in reducing insulin resistance and hyperandrogenemia (the increased production of androgens, common in women with PCOS). Leafy greens, such as spinach, collard greens, and mustard greens contain high amounts compared to other vegetables. One cup of cooked spinach has 157mg of magnesium (37% DV). Leafy greens are also filled with nutritious vitamins and minerals, such as iron, manganese, and Vitamins A, C, and K.

Fibrous, non-starchy green vegetables can be consumed with each meal. They are helpful in reducing blood sugar and they add to the magnesium daily value needed, adds Dr. Sethi Dalai.

This family of nutrient-dense plants of chickpeas, beans, lentils, peas, and soybeans are loaded with rich fiber, protein, and zero cholesterol. A 2018 study published in Nutrients examined the association between certain beans and pulses in effectively reducing insulin resistance. Findings supported how legumes such as soybeans and pulses are known to be beneficial for diabetes management as a result of their low glycemic index, which leads to a low rise in blood sugar after consumption. Research shows that women who have PCOS have a higher risk of developing type 2 diabetes, due to high glucose levels and insulin resistance. Lentils and chickpeas can be an easy protein boost to your plant-based tacos, salads, and soup!

Unsaturated fats have been proven to balance hormones and optimize insulin levels in women with PCOS. Healthy fats such as certain nuts and seeds are filled with Omega-3 fatty acids, which has abundant health benefits for the body and the brain. A study published in 2017 in Experimental and Clinical Endocrinology & Diabetes found that supplementing with omega-3 fatty acids for 12 weeks drove a reduction in testosterone levels and improved insulin resistance in women with PCOS, through a randomized double-blind placebo-controlled trial.

Use healthier, less processed oils such as olive or avocado oil with higher heat cooking. Try eating avocado in your salad or with your breakfast. Your breakfast should have adequate fat and protein, such as egg (or substitute a plant-based protein if you are vegan) and avocado, says Dr. Sethi Dalai.

Findings from a 2018 study published in The Journal of Metabolic Diseases supported evidence that oxidative stress and decreased antioxidant status are often linked with PCOS. Colorful berries are extremely beneficial for patients with PCOS as they are filled with antioxidants that may help reduce oxidative stress. They also help control free radicals, unstable molecules that can cause damage to your body when in high amounts. Berries contain polyphenols, which have been shown to help in the management of weight, diabetes, and indigestion. Highbush blueberries (560mg), blackberries (260mg), and strawberries (235mg) are some of the colorful berries highest in polyphenols.

Berries are a good fruit choice because they are high in fiber and low in sugar compared to other fruits like mango, watermelon, or banana, says Dr. Sethi Dalai. They can also serve as a healthy dessert option.

The gut microbiota is the largest population of microorganisms in the human body, which reside in the intestine. Research has shown that gut microbiota can cause insulin resistance and may contribute to the development of PCOS by impacting energy absorption, the brain-gut axis, and much more. A 2020 study explored the consumption of probiotics to treat PCOS. Findings from the research suggested that probiotics can be used to regulate gut microbiota and treat metabolic diseases, which also points to a new therapeutic direction for the treatment of the metabolic abnormalities associated with PCOS. While many dairy products are filled with probiotics, there are a multitude of fermented vegan options such as sauerkraut, pickles, kimchi, and kombucha.

A study published in 2018 in the European Journal of Endocrinology supported evidence that women with PCOS are at high risk of contracting type 2 diabetes than their counterparts. Whole grains high in fiber, such as rolled oats, bulgur, quinoa, and buckwheat, are slow-release carbohydrates. This means that they have a low glycemic index, releasing sugar into the blood at a slower, more regular pace. Therefore, they are less likely to cause spikes in blood sugar levels. They will also give you a boost of energy and keep you satiated for long periods of time.

If you are choosing between simple versus complex carbohydrates, always choose complex since the glycemic index is lower, adds Dr. Sethi Dalai. While whole grains are higher in fiber, I would not recommend excessive consumption for someone with insulin resistance.

Visit link:
The 6 Best Foods to Eat to Alleviate PCOS Symptoms - The Beet

More Content Now

ThursdaySep24,2020at12:01AM

Gallstones are hardened deposits of digestive fluid that can form in your gallbladder, an organ on the right side of your abdomen that holds bile to be released into your small intestine.

Gallstones range in size from as small as a grain of sand to as large as a golf ball, according to the Mayo Clinic. Some people develop just one gallstone, while others develop many gallstones at the same time.

People who develop gallstones and experience symptoms (caused when gallstones lodge in a duct, resulting in a blockage) often require surgery to remove them. Those without symptoms, however, usually dont require treatment.

Symptoms include:

Sudden and rapidly intensifying pain in the upper right portion of your abdomen and/or the center of your abdomen, just below your breastbone Back pain between your shoulder blades Pain in your right shoulder Nausea or vomitingPain associated with gallstones can last several minutes to a few hours.See a doctor if you experience pain so intense that you cant sit still or find a comfortable position, yellowing of your skin and the whites of your eyes (jaundice), or high fever with chills.Possible causes of gallstones: Your bile contains too much cholesterol. Normally, your bile contains enough chemicals to dissolve the cholesterol excreted by your liver. Your bile contains too much bilirubin, a chemical produced when your body breaks down red blood cells. Certain conditions cause your liver to make too much bilirubin, including cirrhosis, biliary tract infections and certain blood disorders. Your gallbladder doesnt empty correctly. Possible risk factors: Being female Being 40 or older Being a Native American Being a Mexican American Being overweight or obese Being sedentary Being pregnant Eating a high-fat diet Eating a high-cholesterol diet Eating a low-fiber diet Having a family history of gallstones Having diabetes Having certain blood disorders, such as sickle cell anemia or leukemia Losing weight very quickly Taking medications that contain estrogen, such as oral contraceptives or hormone therapy drugs Having liver diseaseTo reduce risk of gallstones: Dont skip meals or fast. Try to stick to your usual meal times each day. Lose weight gradually, a maximum of 1-2 pounds per week. Eat more high-fiber foods, such as fruits, vegetables and whole grains. Maintain a healthy weight.

Read more:
Gallstones: What they are, how to prevent them - The Providence Journal

Global Bone Marrow Transplant Rejection Treatment Market reports provide in-depth analysis of Top Players, Geography, End users, Applications, Competitor analysis, Revenue, Price, Gross Margin, Market Share, Import-Export data, Trends and Forecast. The study will feature estimates in terms of sales revenue and consumption from 2020 to 2025, at the global level and across the major regions mentioned above. The study has been created using a unique research methodology specifically designed for this market.

Quantitative information includes Bone Marrow Transplant Rejection Treatment market estimates and forecast for a upcoming years, at the global level, split across the key segments covered under the scope of the study, and the major regions and countries. Sales revenue and consumption estimates, year-on-year growth analysis, price estimation and trend analysis, etc. will be a part of quantitative information for the mentioned segments and regions/countries.

Request a Sample of Bone Marrow Transplant Rejection Treatment Market Research Report with 134 pages and Analysis of Key Players at https://www.insidemarketreports.com/sample-request/4/499281/Bone-Marrow-Transplant-Rejection-Treatment

We encourage businesses to become economically viable, socially acceptable, ethical & yet revolutionary research in technology as well as its profitable marketing with a greater conscience.

Qualitative information will discuss the key factors driving the restraining the growth of the market, and the possible growth opportunities of the market, regulatory scenario, value chain and supply chain analysis, export and import analysis, attractive investment proposition, and Porters 5 Forces analysis among others will be a part of qualitative information. Further, justification for the estimates for each segments, and regions will also be provided in qualitative form.

The major types mentioned in the report are Azathioprine, Adrenocorticotropic Hormone, Cyclophosphamide, Cyclosporine A, Others and the applications covered in the report are Hospital, Clinic, Others,.

Major players profiled in the report include The Bellicum Pharmaceuticals, Inc., Bio-Cancer Treatment International Limited, Biogen Inc, Boryung Pharmaceutical Co., Ltd., Bristol-Myers Squibb Company, Cantex Pharmaceuticals, Inc., Capricor Therapeutics, Inc., Cell Source, Inc., Cell2B S.A., CellECT Bio, Inc., Cleveland BioLabs, Inc., Compugen Ltd., Cynata Therapeutics Limited, Cytodyn Inc., Dompe Farmaceutici S.p.A., Dr. Falk Pharma GmbH, Escape Therapeutics, Inc., F. Hoffmann-La Roche Ltd., Fate Therapeutics, Inc., Generon (Shanghai) Corporation Ltd., Gilead Sciences, Inc., GlaxoSmithKline Plc, Idera Pharmaceuticals, Inc..

The study will also feature the key companies operating in the industry, their product/business portfolio, market share, financial status, regional share, segment revenue, SWOT analysis, key strategies including mergers and acquisitions, product developments, joint ventures and partnerships an expansions among others, and their latest news as well. The study will also provide a list of emerging players in the Bone Marrow Transplant Rejection Treatment market.

Based on regions, the market is classified into North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The study will provide detailed qualitative and quantitative information on the above mentioned segments for every region and country covered under the scope of the study.

Furthermore, this study will help our clients solve the following issues:

This study will address some of the most critical questions which are listed below:

Place an order to get this report at https://www.insidemarketreports.com/buy-now/4/499281/Bone-Marrow-Transplant-Rejection-Treatment/single

Purchase this Report now by availing up to 40% Discount and free consultation.Limited offer only.

About Inside Market Reports

Inside Market Reports provides the most comprehensive database of market intelligence reports. We provide quantified B2B research on 70,000 high growth emerging opportunities/threats which will impact 65% to 75% of Global Businesses, with 350+ Million easily actionable statistics with tables, figures and datasets (sales forecasts, market shares, production data).

Our Research Analysts have in-depth knowledge of various types of reports in their respective industries. They will help you refine search parameters, locate the full range of available reports, review the scope and methodology of the reports you choose, and give you informed and objective advice to ensure that you are making the right research purchase decision.

We constantly engage our market research partners to focus on the emerging market and technologies thus providing our clients with clarity insights and projections. The latest market research reports on industries, the developments and innovations have all the trends of well-known industries and prospects.

For all your Research needs, reach out to us at:

Email: [emailprotected]

Phone: +1-617-230-0741

Go here to read the rest:
Global Bone Marrow Transplant Rejection Treatment Market Outlook by Types, Applications, End Users and Opportunities to 2025 - The Daily Chronicle

By Pam BelluckAnnrene Rowe was getting ready to celebrate her 10th wedding anniversary this summer when she noticed a bald spot on her scalp. In the following days, her thick, shoulder-length hair started falling out in clumps, bunching up in the shower drain.

I was crying hysterically, said Rowe, 67, of Anna Maria, Florida.

Rowe, who was hospitalised for 12 days in April with symptoms of the coronavirus, soon found strikingly similar stories in online groups of Covid-19 survivors. Many said that several months after contracting the virus, they began shedding startling amounts of hair.

Doctors say they too are seeing many more patients with hair loss, a phenomenon they believe is indeed related to the coronavirus pandemic, affecting both people who had the virus and those who never became sick.

In normal times, some people shed noticeable amounts of hair after a profoundly stressful experience such as an illness, major surgery or emotional trauma.

Theres many, many stresses in many ways surrounding this pandemic, and were still seeing hair loss because a lot of the stress hasnt gone away, said Dr. Shilpi Khetarpal, an associate professor of dermatology at the Cleveland Clinic.

Before the pandemic, there were weeks when Khetarpal didnt see a single patient with hair loss of this type. Now, she said, about 20 such patients a week come in. One was a woman having difficulty home-schooling two young children while also working from home. Another was a second-grade teacher anxiously trying to ensure that all her students had computers and internet access for online instruction.

In a July survey about post-Covid symptoms among 1,567 members of a survivors group, 423 people reported unusual hair loss, according to the group, Survivor Corps, and Natalie Lambert, an associate research professor at Indiana University School of Medicine, who helped conduct the survey.

Making healthy lifestyle changes in terms of diet, exercise and managing stress, in addition to other factors, can go a long way in helping the immune system get the boost it requires.

On International Immunology Day, Chennai-based clinical nutritionist, lactation consultant and diabetes educator - Ramya Ramachandran - shares five tips that can give your life a healthy spin.

Ginger, garlic, star anise, omega-3 fats, flax seeds are some foods that have antiviral and anti-inflammatory properties. These can be included in your meals daily. Its also important to focus on micronutrients which have a major impact on health.

To add the required amount of micronutrients to any diet, one can look at home fortification as an alternative. In this method, a commercially available product is conveniently utilised on a daily basis to prevent nutrition deficiencies. Power mixes of rice and flour avaiable in the market is one such example of food fortification, which increases the micronutrient value of home-cooked meals.

Quit SmokingThis is one of the basic requirements. Smoking is a big NO for the overall wellbeing of the body as it negatively impacts on both adaptive and innate immunity. It slowly kills the natural effectiveness of the immune systems defences. If you are a regular smoker, it is advisable to quit it as soon as possible. One can also adopt alternatives like nicotine patches as it can helps to quit smoking and are relatively less harmful.

Rest Your Mind And Soul With MeditationChronic stress is responsible for releasing hormone cortisol, which can ruin the overall immune response of the body. Meditation goes a long way in keeping stress in check. Various mobile-based apps can help one to remain peaceful and mindful throughout the day with various features. Other healthy strategies to deal with stress may include yoga and pranayama.

A minimum of 7-8 hours of regular sleep is a must to maintain a healthy circadian rhythm, and help the bodys T-Cells (also known as immune cells) to kill the pathogens. A night of good sleep also helps in burning calories.

Some of them had Covid, but not all of them, she said. Its the stress of the situation. They were apart from their families. They worked for many hours.

For most patients the condition should be temporary, doctors say, but it could last months.

There are two types of hair loss the pandemic seems to be triggering, experts say.

In one condition, called telogen effluvium, people shed much more than the typical 50 to 100 hairs per day, usually beginning several months after a stressful experience. It essentially involves a shifting or tripping of the hair growth system, said Dr. Sara Hogan, a dermatologist at the David Geffen School of Medicine at the University of California, Los Angeles, who has been seeing up to seven patients a day with the condition.

In healthy hair cycles, most hairs are in a growing phase, with a small percentage in a short resting phase and only about 10% of hairs in a shedding or telogen phase. But with telogen effluvium, people are shedding more, growing less, Khetarpal said, and up to 50% of hair might skip ahead to the shedding phase, with only about 40% in the growth phase.

The phenomenon, which some women also experience after pregnancy, typically lasts about six months, but if stressful situations persist or recur, some people develop a chronic shedding condition, Hogan said.

The other hair loss condition that is increasing now is alopecia areata, in which the immune system attacks hair follicles, usually starting with a patch of hair on the scalp or beard, said Dr. Mohammad Jafferany, a psychiatrist and dermatologist at Central Michigan University.

It is known to be associated with or exacerbated by psychological stress, Jafferany said.

Guttman-Yassky said that she has seen a huge increase in this type of alopecia.

Not all of the patients had Covid-19, she said, but the ones who did tended to progress very quickly from one or two bald patches to losing hair all over the body, including eyebrows and eyelashes. She said that might be because the storm of inflammation that some Covid patients experience elevates immune molecules linked to conditions like alopecia.

Experts dont know exactly why stress triggers these conditions, which affect both women and men. It might be related to increased levels of cortisol, a stress hormone, or to effects on blood supply, Hogan said.

The hair loss itself can cause more stress, Khetarpal said, especially for women, whose hair is often more closely tied to identity and self-confidence.

Its your trademark, said Mary Lou Ostling, 77, a retired educator who lives in the Stuyvesant Town neighborhood of Manhattan. She was hospitalized for Covid-19 for eight days in the early spring and later noticed that my hair started coming out in chunks, she said. I always was clearing hair out of the comb, brush, the sink.

Ostling said she also could tell that her hair wasnt growing much because she wasnt seeing roots that contrasted with the color she had previously dyed it.

Ive always had very long, very thick, very curly hair, she said.

But in July, she had it cut.

I couldnt deal with it anymore, Ostling said.

When she came home from the hairdresser, she said, my husband was just staring at me. He said, I think I have a different wife. It was very depressing. She said she has finally begun to detect some hair growth.

Experts recommend good nutrition, vitamins like biotin and stress-reduction techniques like yoga, scalp massage or mindfulness meditation. Some also recommend minoxidil, a hair growth drug, but Hogan warns patients that it can initially cause more hair loss before it starts working.

With alopecia areata, Guttman-Yassky said, some cases resolve without treatment and some are helped by steroid injections, but some can become permanent, especially if not treated early.

For people depressed or traumatized by hair loss, Jafferany recommends psychotherapy but not necessarily medication because some antidepressants and anti-anxiety medications can exacerbate hair loss.

When Liz Weidhorn, 44, of Fair Lawn, New Jersey, who tested positive for Covid-19 in March, noticed members of an online COVID group bemoaning hair loss, she told herself that if it happened to her, I will take it with grace, and Ill get a kick-ass hat, she recalled.

But recently after showering, I looked at my wet hair, and I could see so much scalp, she said, and I couldnt believe how emotional I got. She cried and called her husband in to look at it.

Its really shocking, she said. It got me very sad.

Weidhorn, who writes a blog about baking pastry, started taking biotin, had her mother cut her hair and is considering getting a headband.

Rowe, who managed the front desk for a wellness spa, has gone further.

I tried putting my hair in one of those messy buns, but it looks terrible with the bald spots on the sides, she said. So she got wigs: a really short pixie one, a pageboy one, a long curly one and a strawberry blonde one, she said. Im trying to make the best of it.

Hogan said some patients find the situation so upsetting they avoided washing or brushing their hair because they noticed the hair loss more during those activities. She tells them they shouldnt be afraid of normal grooming.

She added, Patients dont like this when I say this, but they come around to it: Hair is not crucial for your survival.

Original post:
Losing hair is turning out to be another consequence of the pandemic, not just for Covid-19 patients but also those who haven't caught the virus -...

Not all of the patients had Covid-19, she said, but the ones who did tended to progress very quickly from one or two bald patches to losing hair all over the body, including eyebrows and eyelashes. She said that might be because the storm of inflammation that some Covid patients experience elevates immune molecules linked to conditions like alopecia.

Experts dont know exactly why stress triggers these conditions, which affect both women and men. It might be related to increased levels of cortisol, a stress hormone, or to effects on blood supply, Dr. Hogan said.

The hair loss itself can cause more stress, Dr. Khetarpal said, especially for women, whose hair is often more closely tied to identity and self-confidence.

Its your trademark, said Mary Lou Ostling, 77, a retired educator who lives in the Stuyvesant Town neighborhood of Manhattan. She was hospitalized for Covid-19 for eight days in the early spring and later noticed that my hair started coming out in chunks, she said. I always was clearing hair out of the comb, brush, the sink.

Ms. Ostling said she also could tell that her hair wasnt growing much because she wasnt seeing roots that contrasted with the color she had previously dyed it.

Ive always had very long, very thick, very curly hair, she said. But in July, I simply had a lot of it all cut off. I couldnt deal with it anymore.

When she came home from the hairdresser, she said, my husband was just staring at me. He said, I think I have a different wife. It was very depressing. She said she has finally begun to detect some hair growth.

See the article here:
Losing Your Hair Can Be Another Consequence of the Pandemic - The New York Times

The Global Blood Testing Market analysis report published on Dataintelo.com is a detailed study of market size, share and dynamics covered in XX pages and is an illustrative sample demonstrating market trends. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact is covered in the report. It covers the entire market with an in-depth study on revenue growth and profitability. The report also delivers on key players along with strategic standpoint pertaining to price and promotion.

Get FREE Exclusive PDF Sample Copy of This Report: https://dataintelo.com/request-sample/?reportId=79004

The Global Blood Testing Market report entails a comprehensive database on future market estimation based on historical data analysis. It enables the clients with quantified data for current market perusal. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and regional analysis. Listed out are key players, major collaborations, merger & acquisitions along with upcoming and trending innovation. Business policies are reviewed from the techno-commercial perspective demonstrating better results. The report contains granular information & analysis pertaining to the Global Blood Testing Market size, share, growth, trends, segment and forecasts from 2020-2026.

With an all-round approach for data accumulation, the market scenarios comprise major players, cost and pricing operating in the specific geography/ies. Statistical surveying used are SWOT analysis, PESTLE analysis, predictive analysis, and real-time analytics. Graphs are clearly used to support the data format for clear understanding of facts and figures.

Customize Report and Inquiry for The Blood Testing Market Report: https://dataintelo.com/enquiry-before-buying/?reportId=79004

Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Primary research, interviews, news sources and information booths have made the report precise having valuable data. Secondary research techniques add more in clear and concise understanding with regards to placing of data in the report.

The report segments the Global Blood Testing Market as:Global Blood Testing Market Size & Share, by Regions

Global Blood Testing Market Size & Share, by ProductsGlucoseLipidBUNA1CCRPVitamin DALTASTThyroid Stimulating Hormone

Global Blood Testing Market Size & Share, ApplicationsHospitalsClinic and Diagnostic CentersOthers

Key PlayersAbbott LaboratoriesBio-Rad LaboratoriesF. Hoffmann La RocheSiemens Healthineers

Avail the Discount on this Report @ https://dataintelo.com/ask-for-discount/?reportId=79004

Dataintelo offers attractive discounts on customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About DataIntelo:DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario, CA 91764, United States.Phone No: USA: +1 909 545 6473 | IND: +91-7000061386Email: [emailprotected]Website: https://dataintelo.com

Go here to see the original:
Blood Testing Market 2020 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis And Forecast To 2026 |...

Image: Breast cancer cell. Credit:Anne Weston, Francis Crick Institute,CC BY-NC

Read more news presented at the 2020 European Society for Medical Oncology (ESMO) meeting:

A new treatment for breast cancer patients with hormone receptor (HR+) early stage disease who are at a high risk of recurrence has been shown to reduce the risk by 25 per cent in the first two years, according to a new study.

The results of the monarchE study presented at the European Society for Medical Oncology Virtual Congress (ESMO) and published simultaneously in the Journal of Clinical Oncology (JCO), have been described as one of the most promising breakthroughs for patients with this type of breast cancer in the last 20 years.

The global randomised Phase III study was led by The Royal Marsden NHS Foundation Trust.The Institute of Cancer Research, London, works in close partnership with The Royal Marsden to take research into the clinic.

The trial involved 5,637 patients in 38 countries and tested if patients taking the CDK 4/6 inhibitor abemaciclib along with hormone therapy following standard of care treatments (chemotherapy, surgery and/or radiotherapy) would reduce the risk of recurrence compared with the standard hormone treatment alone.

Approximately 70 per cent of breast cancer patients have hormone receptor positive tumours, and of those a proportion of patients will have a higher risk of relapsing in the first two of years.

Patients with disease that has spread to lymph nodes, a large tumour size at the time of diagnosis, or an increased cellular proliferation (determined by high grade of the tumour, or number of dividing cells) were considered to be at high risk of recurrence and recruited to the study.

The study found a 25 per cent reduction in recurrence of cancer within the first two years when abemaciclib was added to the standard hormone therapy compared with the hormone therapy alone. During this time 11.3 per cent of patients in the control group had a relapse of their cancer compared with 7.8 per cent of those in the abemaciclib group.

Professor Stephen Johnston, Consultant Medical Oncologist at The Royal Marsden and Professor of Breast Cancer Medicine at The Institute of Cancer Research, London, said:

The monarchE research has given us a confidence that we will soon be to offer our high risk HR+ patients a greater chance of keeping them cancer free. While there have been many advances in other early breast cancer subtypes such as HER2 positive disease, there has been no significant advancements for the large group of patients who have hormone receptor positive breast cancer since the late 1990s when aromatase inhibitors were introduced. This research could potentially save many lives in the future.

Patient Sarah Ryder, 57, participated in the trial. She said:

When I was referred to The Royal Marsden last year and Professor Johnston told me about the monarchE trial I was so pleased to be part of something that could potentially save my life. By that stage my cancer had spread to 23 lymph nodes and I honestly did not feel much hope.

The trial has helped me believe in a future again. I can see my daughter grow up, go off to university next year and maybe have a family of her own one day.

Breast cancer research at The Royal Marsden is funded by The Royal Marsden Cancer Charity and National Institute for Health Research. The monarchE trial was funded by Eli Lilly and Company.

Read the original here:
ESMO 2020: Research breakthrough offers new hope for high risk patients with HR+ breast cancer - The Institute of Cancer Research